| 1 | 1 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 💬
|
| 2 | 10 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 💬
|
| 3 | 2-deoxy-2 [F-18] fluoro-2-d-glucose | [1] D-glucose D-glucose | [1] Glucose
Glucose
💬
| - | - | [1] 49 49 💬
|
| 4 | 2-HOBA acetate (2-Hydroxybenzlamine acetate) | [1] Acetate Acetate | - | - | - | [1] 49 49 💬
|
| 5 | 4 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 💬
|
| 6 | 626 | - | - | - | - | [1] 49 49 💬
|
| 7 | 81mg aspirin | - | - | - | - | [1] 49 49 💬
|
| 8 | [015628086] | - | - | - | - | [1] 49 49 💬
|
| 9 | [045450032] | - | - | - | - | [1] 49 49 💬
|
| 10 | [045833011] | - | - | - | - | [1] 49 49 💬
|
| 11 | [ABBV-105] | - | - | - | - | [1] 49 49 💬
|
| 12 | [ABT-494] | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 13 | [ACT-334441] | - | - | - | - | [1] 49 49 💬
|
| 14 | [AMG 570] | - | - | - | - | [1] 49 49 💬
|
| 15 | [AMG 592] | - | - | - | - | [2] 49 49, 97 💬
|
| 16 | [BIIB059] | - | - | - | - | [1] 49 49 💬
|
| 17 | [CDP7657] | - | - | - | - | [1] 49 49 💬
|
| 18 | [LY3009104] | - | - | - | - | [4] 46 46, 49, 93, 107 💬
|
| 19 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 20 | [PF-06700841 25mg] | - | - | - | - | [1] 49 49 💬
|
| 21 | [PF-06700841 5 mg] | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 22 | [SAR441344] | - | - | - | - | [1] 49 49 💬
|
| 23 | [VAY736] | - | - | - | - | [4] 49 49, 53, 61, 63 💬
|
| 24 | A-319 | - | - | - | - | [2] 46 46, 49 💬
|
| 25 | A-623 | - | - | - | - | [1] 49 49 💬
|
| 26 | AB-101 | - | - | - | - | [4] 35 35, 44, 46, 49 💬
|
| 27 | Abacavir | [1] Abacavir Abacavir | [2] Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | [5] 2 2, 49, 135, 265, 325 💬
|
| 28 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 29 | Abatacept also known as Orencia also known as CTLA4-Ig | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 49 49 💬
|
| 30 | ABBV-105 | - | - | - | - | [2] 46 46, 49 💬
|
| 31 | ABBV-319 | - | - | - | - | [1] 49 49 💬
|
| 32 | ABBV-519 | - | - | - | - | [2] 46 46, 49 💬
|
| 33 | Abetimus | [1] Abetimus Abetimus | [1] Abetimus sodium
Abetimus sodium
💬
| - | - | [2] 49 49, 223 💬
|
| 34 | ABETIMUS SODIUM | [1] Abetimus Abetimus | [1] Abetimus sodium
Abetimus sodium
💬
| - | - | [1] 49 49 💬
|
| 35 | Abetimus sodium (LJP 394) | [1] Abetimus Abetimus | [1] Abetimus sodium
Abetimus sodium
💬
| - | - | [2] 49 49, 223 💬
|
| 36 | ABR-215757 | - | - | - | - | [2] 49 49, 51 💬
|
| 37 | ABT-199 | - | - | - | - | [1] 49 49 💬
|
| 38 | ABT-494 | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 39 | AC0058TA | - | - | - | - | [1] 49 49 💬
|
| 40 | Acazicolcept | [1] Acazicolcept Acazicolcept | [1] Acazicolcept
Acazicolcept
💬
| [2] CD28 CD28, ICOS 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 49 49 💬
|
| 41 | ACE1831 | - | - | - | - | [2] 49 49, 300 💬
|
| 42 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [19] 11 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
|
| 43 | Acetaminophen/paracetamol | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 35 35, 49 💬
|
| 44 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 45 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 46 | Acido Micofenolico | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 49 49, 51 💬
|
| 47 | ACM | - | - | - | - | [1] 49 49 💬
|
| 48 | ACT-334441 | - | - | - | - | [1] 49 49 💬
|
| 49 | ACT100 Injection | - | - | - | - | [1] 49 49 💬
|
| 50 | Acthar | - | - | - | - | [6] 2 2, 13, 46, 49, 50, 222 💬
|
| 51 | Acthar Gel | - | - | - | - | [6] 13 13, 46, 49, 84, 222, 223 💬
|
| 52 | Acthar high dose (80 U) | - | - | - | - | [1] 49 49 💬
|
| 53 | Acthar low dose (40 U) | - | - | - | - | [1] 49 49 💬
|
| 54 | Ad26.COV2.S | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 55 | ADI-001 | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 56 | Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil | [3] Methylprednisolone Methylprednisolone, Mycophenolate mofetil, Prednisone | [5] Methylprednisolone
Methylprednisolone
,
Prednisone
,
Mycophenolate mofetil
,
Methylprednisolone acetate
,
Mycophenolate mofetil hydrochloride
💬
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬
| [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 49 49 💬
|
| 57 | Administration of methylprednisolone, paracetamol and dexchlorpheniramine | [2] Dexchlorpheniramine Dexchlorpheniramine, Methylprednisolone | [3] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
,
Dexchlorpheniramine
💬
| [2] HRH1 HRH1, NR3C1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 58 | Afimetoran | [1] Afimetoran Afimetoran | [1] Afimetoran
Afimetoran
💬
| - | - | [1] 49 49 💬
|
| 59 | Afimetoran (10mg) | [1] Afimetoran Afimetoran | [1] Afimetoran
Afimetoran
💬
| - | - | [1] 49 49 💬
|
| 60 | Afimetoran (2.5mg) | [1] Afimetoran Afimetoran | [1] Afimetoran
Afimetoran
💬
| - | - | [1] 49 49 💬
|
| 61 | After preconditioning with chemotherapy, F01 will be evaluated. | - | - | - | - | [1] 49 49 💬
|
| 62 | AGS-009 | - | - | - | - | [1] 49 49 💬
|
| 63 | AIDSVAX® B/E | - | - | - | - | [1] 49 49 💬
|
| 64 | AKBM-3031 | - | - | - | - | [1] 49 49 💬
|
| 65 | ALDESLEUCHINA | - | - | - | - | [1] 49 49 💬
|
| 66 | Aldesleukin | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 2 2, 49, 65, 96, 97 💬
|
| 67 | Alfacalcidol | [1] Alfacalcidol Alfacalcidol | [1] Alfacalcidol
Alfacalcidol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 41 41, 46, 49, 50, 96, 107, 222, 223, 235, 238 💬
|
| 68 | ALITRETINOIN | [1] Alitretinoin Alitretinoin | [1] Alitretinoin
Alitretinoin
💬
| [5] RARA RARA, RARB, RXRA, RXRB, RXRG 💬
| [20] Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | [1] 49 49 💬
|
| 69 | Allogeneic bone marrow transplant | - | - | - | - | [1] 49 49 💬
|
| 70 | Allogeneic CD19/BCMA-targeted CAR-?dT cell injection | - | - | - | - | [2] 49 49, 51 💬
|
| 71 | ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD | - | - | - | - | [1] 49 49 💬
|
| 72 | Allogeneic MSC (AlloMSC) | - | - | - | - | [1] 49 49 💬
|
| 73 | Allogeneic stem cell transplantation | - | - | - | - | [5] 19 19, 20, 49, 62, 84 💬
|
| 74 | Allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA | - | - | - | - | [1] 49 49 💬
|
| 75 | Alnuctamab | [1] Alnuctamab Alnuctamab | - | - | - | [1] 49 49 💬
|
| 76 | Alpha-tocopherol | [1] Tocopherol Tocopherol | [1] Tocopherol
Tocopherol
💬
| - | - | [2] 49 49, 215 💬
|
| 77 | ALPN-101 | - | - | - | - | [1] 49 49 💬
|
| 78 | ALX-0061 | - | - | - | - | [2] 46 46, 49 💬
|
| 79 | ALX-0061 150 mg/mL | - | - | - | - | [1] 49 49 💬
|
| 80 | AMG 557 | - | - | - | - | [1] 49 49 💬
|
| 81 | AMG 570 | - | - | - | - | [1] 49 49 💬
|
| 82 | AMG 592 | - | - | - | - | [3] 46 46, 49, 97 💬
|
| 83 | AMG 623 | - | - | - | - | [1] 49 49 💬
|
| 84 | AMG 811 | - | - | - | - | [2] 49 49, 223 💬
|
| 85 | AMG592 | - | - | - | - | [2] 46 46, 49 💬
|
| 86 | AMG811 | - | - | - | - | [1] 49 49 💬
|
| 87 | Anakinra | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [22] 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
|
| 88 | ANIFROLUMAB | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [6] 46 46, 48, 49, 50, 51, 53 💬
|
| 89 | Anifrolumab 1000 mg | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 90 | Anifrolumab 300 mg | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 91 | Anti BAFF (B cell activating factor) | - | - | - | - | [1] 49 49 💬
|
| 92 | Anti LP40 antibody, subclass IgG4 | - | - | - | - | [1] 49 49 💬
|
| 93 | Anti LP40 anticuerpo, subclase IgG4 | - | - | - | - | [1] 49 49 💬
|
| 94 | Anti-BCMA/CD70-CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 95 | Anti-blood dendritic cell antigen 2 | - | - | - | - | [1] 49 49 💬
|
| 96 | Anti-CD19 CAR NK cells (KN5501) | - | - | - | - | [2] 49 49, 63 💬
|
| 97 | Anti-CD19 CAR T cell therapy | - | - | - | - | [5] 48 48, 49, 50, 51, 53 💬
|
| 98 | Anti-CD19 CAR-NK cells | - | - | - | - | [1] 49 49 💬
|
| 99 | Anti-CD19 CAR-T cells | [1] Anti-CD19 CAR-T cells Anti-CD19 CAR-T cells | - | - | - | [6] 46 46, 49, 50, 51, 53, 222 💬
|
| 100 | Anti-CD19 IL-10/IL15 CAR-NK | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 101 | Anti-CD19-CAR-T cells | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 102 | Anti-CD19-CD3E-CAR-T cells | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 103 | Anti-CD19/70 CAR T cells (CHT105) | - | - | - | - | [1] 49 49 💬
|
| 104 | Anti-CD19/BCMA U CAR T cells | - | - | - | - | [4] 46 46, 49, 51, 53 💬
|
| 105 | Anti-CD19/BCMA-UCAR-T cells | - | - | - | - | [4] 46 46, 49, 50, 51 💬
|
| 106 | Anti-CD20 B cell depletion with Truxima | - | - | - | - | [1] 49 49 💬
|
| 107 | Anti-CD28dAb | - | - | - | - | [3] 49 49, 53, 160 💬
|
| 108 | Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody | - | - | - | - | [1] 49 49 💬
|
| 109 | Anti-pandemic H1N1 influenza vaccine | - | - | - | - | [7] 46 46, 48, 49, 50, 51, 53, 107 💬
|
| 110 | Anti-Thymocyte Globulin | - | - | - | - | [19] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
|
| 111 | Anticoagulation | - | - | - | - | [1] 49 49 💬
|
| 112 | APG-2575 | - | - | - | - | [1] 49 49 💬
|
| 113 | Arnovie101 Infusion Intravenous | - | - | - | - | [2] 49 49, 61 💬
|
| 114 | ASF-1096 Cream 0.25% | - | - | - | - | [1] 49 49 💬
|
| 115 | ASF-1096 Cream 0.5% | - | - | - | - | [1] 49 49 💬
|
| 116 | ASF-1096 Cream 1.0% | - | - | - | - | [1] 49 49 💬
|
| 117 | Aspirin | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [10] 22 22, 34, 48, 49, 51, 63, 86, 158, 210, 231 💬
|
| 118 | Aspirin and meloxicam | [1] Meloxicam Meloxicam | [1] Meloxicam
Meloxicam
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 49 49 💬
|
| 119 | Assigned Interventions CD19/BCMA CAR T-cells | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 120 | ATA3219 | - | - | - | - | [1] 49 49 💬
|
| 121 | Atacicept | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [5] 13 13, 46, 49, 66, 222 💬
|
| 122 | Atacicept 150 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 💬
|
| 123 | Atacicept 75 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 💬
|
| 124 | Atacicept 75 milligram (mg) | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 125 | ATHENA CAR-T | - | - | - | - | [1] 49 49 💬
|
| 126 | Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [21] 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
| 127 | Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-positive viable T cells/kg). | [1] Anti-CD19 CAR-T cells Anti-CD19 CAR-T cells | - | - | - | [1] 49 49 💬
|
| 128 | Autologous CD19-BCMA Dual-Target CAR T-Cell Therapy | - | - | - | - | [5] 13 13, 49, 51, 53, 61 💬
|
| 129 | Autologous CD19-Targeted CAR-T Cells | - | - | - | - | [1] 49 49 💬
|
| 130 | Autologous CD34+HPC transplantation (HSCT) | - | - | - | - | [1] 49 49 💬
|
| 131 | Autologous EBV specific CTL infusion | - | - | - | - | [1] 49 49 💬
|
| 132 | Autologous Hematopoietic Stem Cell Transplantation | - | - | - | - | [7] 11 11, 13, 14, 28, 49, 51, 84 💬
|
| 133 | Autologous peripheral blood stem cell transplantation | - | - | - | - | [9] 28 28, 40, 41, 42, 45, 46, 49, 63, 283 💬
|
| 134 | Aviptadil | [1] Aviptadil Aviptadil | [1] Aviptadil
Aviptadil
💬
| - | - | [4] 49 49, 51, 84, 86 💬
|
| 135 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 136 | Azathioprine (AZA) | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [5] 13 13, 19, 49, 55, 97 💬
|
| 137 | AZD0120 | - | - | - | - | [4] 28 28, 46, 49, 51 💬
|
| 138 | AZD5492 | - | - | - | - | [2] 46 46, 49 💬
|
| 139 | Balanced diet | - | - | - | - | [1] 49 49 💬
|
| 140 | Baricinitib | - | - | - | - | [1] 49 49 💬
|
| 141 | Baricitinib | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [24] 2 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
| 142 | BCD-256 | - | - | - | - | [1] 49 49 💬
|
| 143 | BCMA-CD19 CAR-T therapy | - | - | - | - | [6] 48 48, 49, 51, 53, 56, 64 💬
|
| 144 | BCMA/CD19 CAR-T cells | - | - | - | - | [2] 49 49, 53 💬
|
| 145 | BCMA/CD70 CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 146 | Behavioral: heart health educational program | - | - | - | - | [1] 49 49 💬
|
| 147 | Behavioral: Physical Exercise Program | - | - | - | - | [1] 49 49 💬
|
| 148 | Behavioral: Questionnaires | - | - | - | - | [3] 28 28, 49, 84 💬
|
| 149 | BELIMUMAB | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [17] 11 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
|
| 150 | Belimumab (GSK1550188) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 151 | Belimumab 1 mg/kg | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 💬
|
| 152 | Belimumab 10 mg/kg | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 43 43, 46, 49 💬
|
| 153 | Belimumab 10 mg/kg plus standard therapy | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 154 | Belimumab 100 mg SC | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 155 | Belimumab 10mg/kg | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 156 | Belimumab 200 mg SC | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 157 | Belimumab 200 mg/mL | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 158 | Belimumab 4 mg/kg | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 💬
|
| 159 | Belimumab autoinjector | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 160 | Belimumab for IV | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 161 | Belimumab for SC | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 162 | Belimumab in SLE patients / Rituximab in RA patients | [2] Belimumab Belimumab, Rituximab | [2] Rituximab
Rituximab
,
Belimumab
💬
| [2] MS4A1 MS4A1, TNFSF13B 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 💬
|
| 163 | Belimumab Injection | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 164 | Belimumab Injection [Benlysta] | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 165 | Belimumab or benlysta | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 166 | Belimumab plus Early Vaccination | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 167 | Belimumab plus Late Vaccination | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 168 | Belimumab Powder for solution for infusion [120 mg/vial] | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 169 | Belimumab Solution for injection (200 mg/ml) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 170 | Benazepril | [1] Benazepril Benazepril | [2] Benazepril hydrochloride
Benazepril hydrochloride
,
Benazepril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [5] 49 49, 57, 218, 222, 224 💬
|
| 171 | Benazepril Pill | [1] Benazepril Benazepril | [2] Benazepril hydrochloride
Benazepril hydrochloride
,
Benazepril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 49 49 💬
|
| 172 | Bendamustine | [1] Bendamustine Bendamustine | [3] Bendamustine hydrochloride
Bendamustine hydrochloride
,
Bendamustine
,
Bendamustine hydrochloride hydrate
💬
| - | - | [6] 13 13, 28, 49, 50, 51, 61 💬
|
| 173 | Benlysta | - | - | - | - | [7] 43 43, 48, 49, 53, 63, 66, 222 💬
|
| 174 | Benlysta (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [4] 11 11, 49, 53, 222 💬
|
| 175 | Benlysta 400 mg powder for concentrate for solution for infusion | - | - | - | - | [2] 43 43, 49 💬
|
| 176 | Benlysta 400 mg powder for concentrate for solution for infusions | - | - | - | - | [1] 49 49 💬
|
| 177 | BENLYSTA? (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 178 | Benlysta® | - | - | - | - | [2] 49 49, 222 💬
|
| 179 | BENLYSTA™ (belimumab) | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 180 | BI 3000202 | - | - | - | - | [1] 49 49 💬
|
| 181 | BI 705564 | - | - | - | - | [1] 49 49 💬
|
| 182 | BIIB059 | - | - | - | - | [1] 49 49 💬
|
| 183 | BIIB059 (litifilimab) | [1] Litifilimab Litifilimab | [1] Litifilimab
Litifilimab
💬
| - | - | [1] 49 49 💬
|
| 184 | Biospecimen Collection | - | - | - | - | [18] 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 185 | Blinatumomab | [1] Blinatumomab Blinatumomab | [1] Blinatumomab
Blinatumomab
💬
| [4] CD19 CD19, CD3D, CD3E, CD3G 💬
| [13] B cell receptor signaling pathway B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [4] 11 11, 46, 49, 222 💬
|
| 186 | Blinatumomab 9ug | [1] Blinatumomab Blinatumomab | [1] Blinatumomab
Blinatumomab
💬
| [4] CD19 CD19, CD3D, CD3E, CD3G 💬
| [13] B cell receptor signaling pathway B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 49 49 💬
|
| 187 | Blisibimod | [1] Blisibimod Blisibimod | [1] Blisibimod
Blisibimod
💬
| - | - | [5] 43 43, 44, 49, 63, 66 💬
|
| 188 | Blood draw | - | - | - | - | [16] 3 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
|
| 189 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 190 | Blood samples | - | - | - | - | [14] 13 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
|
| 191 | Blood test | - | - | - | - | [19] 2 2, 6, 13, 36, 46, 49, 51, 74, 79, 83, 96, 113, 127, 162, 227, 256, 280, 299, 300 💬
|
| 192 | Blood test and principal collection | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 193 | BMS-188667 | - | - | - | - | [10] 46 46, 49, 53, 65, 96, 97, 107, 222, 223, 271 💬
|
| 194 | BMS-931699 | [1] Lulizumab pegol Lulizumab pegol | - | - | - | [3] 49 49, 53, 160 💬
|
| 195 | BMS-986165 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 196 | BMS-986165 Capsule | - | - | - | - | [1] 49 49 💬
|
| 197 | BMS-986165 Tablet | - | - | - | - | [1] 49 49 💬
|
| 198 | BMS-986195 | [1] Branebrutinib Branebrutinib | [1] Branebrutinib
Branebrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [3] 46 46, 49, 53 💬
|
| 199 | BMS-986256 | [1] Afimetoran Afimetoran | [1] Afimetoran
Afimetoran
💬
| - | - | [1] 49 49 💬
|
| 200 | BMS-986256-06, TLR7/8 Antagonist | [1] Afimetoran Afimetoran | [1] Afimetoran
Afimetoran
💬
| - | - | [1] 49 49 💬
|
| 201 | BMS-986326 | - | - | - | - | [1] 49 49 💬
|
| 202 | BMS986195 | - | - | - | - | [3] 46 46, 49, 53 💬
|
| 203 | BNT162b2 | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 204 | BNT162b2, Bivalent | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 205 | Bone densitometry | - | - | - | - | [2] 49 49, 162 💬
|
| 206 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [19] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
|
| 207 | BOS161721 | - | - | - | - | [1] 49 49 💬
|
| 208 | BR-DIM | - | - | - | - | [1] 49 49 💬
|
| 209 | Branebrutinib | [1] Branebrutinib Branebrutinib | [1] Branebrutinib
Branebrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [3] 46 46, 49, 53 💬
|
| 210 | Brentuximab | [1] Brentuximab Brentuximab | - | - | - | [2] 49 49, 51 💬
|
| 211 | Brentuximab vedotin | [2] Brentuximab Brentuximab, Brentuximab vedotin | [1] Brentuximab vedotin
Brentuximab vedotin
💬
| [10] TNFRSF8 TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [13] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [2] 49 49, 51 💬
|
| 212 | Brepocitinib | [1] Brepocitinib Brepocitinib | [1] Brepocitinib
Brepocitinib
💬
| [2] JAK1 JAK1, TYK2 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [5] 49 49, 50, 84, 96, 97 💬
|
| 213 | BRL-301 | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 214 | Bronchoalveolar lavage (BAL fluid) | - | - | - | - | [2] 49 49, 51 💬
|
| 215 | BT063 | - | - | - | - | [1] 49 49 💬
|
| 216 | Budoprutug | [1] Budoprutug Budoprutug | - | - | - | [3] 49 49, 63, 222 💬
|
| 217 | Busulfan | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬
| - | - | [14] 19 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
|
| 218 | CABA-201 | - | - | - | - | [5] 11 11, 13, 35, 49, 51 💬
|
| 219 | Cabozantinib | [1] Cabozantinib Cabozantinib | [2] Cabozantinib
Cabozantinib
,
Cabozantinib s-malate
💬
| [3] AXL AXL, KDR, MET 💬
| [28] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [9] 13 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
|
| 220 | Calcitriol | [1] Calcitriol Calcitriol | [1] Calcitriol
Calcitriol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [11] 18 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
|
| 221 | Calcium | [1] Calcium Calcium | - | - | - | [39] 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 222 | Calcium and Vit D | [1] Calcium Calcium | - | - | - | [1] 49 49 💬
|
| 223 | Campath | - | - | - | - | [3] 49 49, 51, 60 💬
|
| 224 | CAR-T cell | - | - | - | - | [1] 49 49 💬
|
| 225 | CAR-T Therapy | - | - | - | - | [2] 49 49, 51 💬
|
| 226 | CART19 | - | - | - | - | [1] 49 49 💬
|
| 227 | CB-010 | [1] CB-010 CB-010 | - | - | - | [1] 49 49 💬
|
| 228 | CC-220 | - | - | - | - | [1] 49 49 💬
|
| 229 | CC-97540 | - | - | - | - | [5] 11 11, 13, 46, 49, 51 💬
|
| 230 | CC312 | - | - | - | - | [5] 46 46, 49, 51, 61, 63 💬
|
| 231 | CCX168 | - | - | - | - | [6] 43 43, 44, 49, 66, 109, 223 💬
|
| 232 | CD19 CAR-T cell infusion | - | - | - | - | [1] 49 49 💬
|
| 233 | CD19 CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 234 | CD19 UCAR-T cells | - | - | - | - | [5] 48 48, 49, 51, 53, 63 💬
|
| 235 | CD19 Universal CAR-?d T Cells | - | - | - | - | [1] 49 49 💬
|
| 236 | CD19 Universal CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 237 | CD19- BCMA CAR-T cells | - | - | - | - | [4] 43 43, 49, 51, 53 💬
|
| 238 | CD19-BCMA CAR-T cells infusion | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 239 | CD19-CAR-DNT cells | - | - | - | - | [2] 49 49, 51 💬
|
| 240 | CD19/BCMA CAR T-cells | - | - | - | - | [3] 16 16, 49, 61 💬
|
| 241 | CD19/BCMA CAR-T cell therapy | - | - | - | - | [1] 49 49 💬
|
| 242 | CD19/CD22/BCMA CAR-T cells(BZE2204) | - | - | - | - | [2] 49 49, 63 💬
|
| 243 | CD20/BCMA-directed CAR-T cells | - | - | - | - | [4] 11 11, 13, 49, 51 💬
|
| 244 | CD34+ Peripheral Blood Stem Cell Reinfusion | - | - | - | - | [1] 49 49 💬
|
| 245 | CDP3194 | - | - | - | - | [1] 49 49 💬
|
| 246 | CDP7657 | - | - | - | - | [1] 49 49 💬
|
| 247 | CELLCEPT | - | - | - | - | [7] 11 11, 13, 42, 43, 49, 222, 223 💬
|
| 248 | Cenerimod | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 249 | Cenerimod 0.5 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 250 | Cenerimod 1 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 251 | Cenerimod 2 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 252 | Cenerimod 2 mg (ex-4 mg) | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 253 | Cenerimod 4 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 254 | CEP-33457 | - | - | - | - | [1] 49 49 💬
|
| 255 | Certolizumab | - | - | - | - | [6] 46 46, 48, 49, 96, 270, 271 💬
|
| 256 | Certolizumab Pegol | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [10] 37 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
|
| 257 | Cervarix suspensie voor injectie | - | - | - | - | [3] 49 49, 50, 107 💬
|
| 258 | Cevostamab | [1] Cevostamab Cevostamab | [1] Cevostamab
Cevostamab
💬
| [1] CD3E CD3E 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 49 49 💬
|
| 259 | CFZ533 | - | - | - | - | [4] 11 11, 46, 49, 53 💬
|
| 260 | Chloroquine | [1] Chloroquine Chloroquine | [4] Chloroquine phosphate
Chloroquine phosphate
,
Chloroquine
,
Chloroquine hydrochloride
,
Chloroquine sulfate
💬
| - | - | [3] 46 46, 49, 95 💬
|
| 261 | CHOLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 13 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
|
| 262 | Cholecalciferol and C. Xanthorrhiza | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 49 49 💬
|
| 263 | CICLOFOSFAMIDE | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 49 49, 51 💬
|
| 264 | Ciclosporin | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [10] 26 26, 46, 49, 50, 53, 60, 97, 226, 228, 269 💬
|
| 265 | CICLOSPORINA | - | - | - | - | [3] 49 49, 60, 97 💬
|
| 266 | CIMZIA | - | - | - | - | [7] 46 46, 48, 49, 96, 97, 107, 271 💬
|
| 267 | Cizutamig | - | - | - | - | [4] 11 11, 46, 49, 97 💬
|
| 268 | CLN-978 | - | - | - | - | [3] 46 46, 49, 53 💬
|
| 269 | Clofarabine | [1] Clofarabine Clofarabine | [1] Clofarabine
Clofarabine
💬
| [3] POLA1 POLA1, POLA2, RRM1 💬
| [5] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [9] 19 19, 20, 40, 46, 49, 60, 96, 234, 326 💬
|
| 270 | Clopidogrel | [1] Clopidogrel Clopidogrel | [4] Clopidogrel bisulfate
Clopidogrel bisulfate
,
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬
| [1] P2RY12 P2RY12 💬
| [3] Efferocytosis Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬 | [7] 40 40, 49, 51, 62, 71, 86, 222 💬
|
| 271 | CM313 injection | - | - | - | - | [3] 35 35, 49, 63 💬
|
| 272 | CM355 | - | - | - | - | [1] 49 49 💬
|
| 273 | CNCT19 cell injection | - | - | - | - | [2] 49 49, 63 💬
|
| 274 | CNTO1275 | - | - | - | - | [6] 46 46, 49, 84, 93, 96, 97 💬
|
| 275 | CNTY-101 | - | - | - | - | [2] 49 49, 51 💬
|
| 276 | Coenzyme Q10 | - | - | - | - | [11] 2 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
|
| 277 | Collection of samples | - | - | - | - | [4] 49 49, 65, 95, 107 💬
|
| 278 | Combination Product: Anifrolumab + APFS | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 279 | Combination Product: Belimumab | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 280 | Combination Product: Yu-Tone Music Intervention | - | - | - | - | [1] 49 49 💬
|
| 281 | Computed Tomography | - | - | - | - | [13] 26 26, 28, 34, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
| 282 | Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d | - | - | - | - | [1] 49 49 💬
|
| 283 | Continuation of azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 49 49 💬
|
| 284 | Continue IS (B cell depletion therapy) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 285 | Continue IS (MMF or MPA) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 286 | Continue IS (MTX) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 287 | Conventional pharmacotherapy | - | - | - | - | [1] 49 49 💬
|
| 288 | Conventional Therapy | - | - | - | - | [5] 14 14, 49, 67, 97, 222 💬
|
| 289 | Corticosteroids | - | - | - | - | [13] 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 222, 223, 296, 300 💬
|
| 290 | Corticosteroids (prednisone or prednisolone) | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 49 49, 223 💬
|
| 291 | COVID-19 vaccine | - | - | - | - | [4] 46 46, 49, 51, 97 💬
|
| 292 | CPTX2309 | - | - | - | - | [2] 46 46, 49 💬
|
| 293 | CRC01 | - | - | - | - | [1] 49 49 💬
|
| 294 | Creatine | [1] Creatine Creatine | - | - | - | [18] 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
|
| 295 | Creatinine | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [9] 2 2, 46, 49, 60, 66, 70, 96, 97, 222 💬
|
| 296 | Crestor | - | - | - | - | [3] 49 49, 79, 299 💬
|
| 297 | CS20AT04 (allogenic bone marrow derived mesenchymal stem cell) | - | - | - | - | [1] 49 49 💬
|
| 298 | Csa | - | - | - | - | [2] 49 49, 60 💬
|
| 299 | CSM allogéniques issues de cordons ombilicaux ( MTI-PP) | - | - | - | - | [1] 49 49 💬
|
| 300 | CTLA4-IgG4m (RG2077) | - | - | - | - | [1] 49 49 💬
|
| 301 | CTLA4Ig | - | - | - | - | [5] 46 46, 49, 96, 223, 271 💬
|
| 302 | CUG252 | - | - | - | - | [1] 49 49 💬
|
| 303 | Cumulative corticosteroid exposure | - | - | - | - | [1] 49 49 💬
|
| 304 | Current standard of care treatment options | - | - | - | - | [1] 49 49 💬
|
| 305 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 306 | Cyclophosphamide (CYC) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 49 49, 221 💬
|
| 307 | Cyclophosphamide LD | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 49 49 💬
|
| 308 | Cyclophosphamide-prednisone-azathioprine | [3] Azathioprine Azathioprine, Cyclophosphamide, Prednisone | [5] Azathioprine
Azathioprine
,
Cyclophosphamide
,
Prednisone
,
Azathioprine sodium
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 309 | Cyclosporin A | - | - | - | - | [12] 46 46, 49, 53, 54, 56, 60, 63, 93, 95, 113, 164, 222 💬
|
| 310 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 311 | Cyclosporine A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [12] 19 19, 20, 36, 49, 50, 53, 58, 60, 107, 228, 234, 283 💬
|
| 312 | CYMBALTA | - | - | - | - | [3] 6 6, 13, 49 💬
|
| 313 | Cytarabine | [1] Cytarabine Cytarabine | [2] Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | [8] 11 11, 13, 14, 25, 34, 49, 60, 65 💬
|
| 314 | D-2570 | - | - | - | - | [2] 49 49, 97 💬
|
| 315 | D-glucose | [1] D-glucose D-glucose | [1] Glucose
Glucose
💬
| - | - | [3] 49 49, 86, 88 💬
|
| 316 | Dapagliflozin | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [16] 6 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
|
| 317 | DAPIROLIZUMAB PEGOL | [1] Dapirolizumab pegol Dapirolizumab pegol | - | - | - | [2] 13 13, 49 💬
|
| 318 | Dapirolizumab pegol (DZP) | [1] Dapirolizumab pegol Dapirolizumab pegol | - | - | - | [1] 49 49 💬
|
| 319 | Daratumumab | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [13] 13 13, 16, 28, 39, 46, 48, 49, 60, 63, 222, 223, 288, 331 💬
|
| 320 | Daratumumab Injection | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬
| [1] CD38 CD38 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [4] 16 16, 28, 49, 63 💬
|
| 321 | Darzalex | - | - | - | - | [3] 28 28, 49, 63 💬
|
| 322 | Daxdilimab | [1] Daxdilimab Daxdilimab | [1] Daxdilimab
Daxdilimab
💬
| [1] LILRA4 LILRA4 💬
| [2] B cell receptor signaling pathway B cell receptor signaling pathway, Osteoclast differentiation 💬 | [2] 49 49, 50 💬
|
| 323 | DB-2304 | - | - | - | - | [1] 49 49 💬
|
| 324 | Dehydroepiandrosterone | - | - | - | - | [3] 49 49, 53, 83 💬
|
| 325 | Dehydroepiandrosterone (DHEA) | - | - | - | - | [1] 49 49 💬
|
| 326 | DELTACORTENE*20CPR 5MG | - | - | - | - | [3] 49 49, 97, 113 💬
|
| 327 | Dengue 1,2,3,4 (attenuated) vaccine | - | - | - | - | [8] 40 40, 43, 44, 46, 48, 49, 51, 107 💬
|
| 328 | Depletion of CD3/CD19 in an autologous stem cell transplant | - | - | - | - | [2] 49 49, 51 💬
|
| 329 | Descartes-08 | - | - | - | - | [3] 11 11, 49, 50 💬
|
| 330 | Deucravacitinib | [1] Deucravacitinib Deucravacitinib | [1] Deucravacitinib
Deucravacitinib
💬
| [1] TYK2 TYK2 💬
| [17] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | [10] 36 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
|
| 331 | Dexchlorpheniramine | [1] Dexchlorpheniramine Dexchlorpheniramine | [1] Dexchlorpheniramine
Dexchlorpheniramine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 49 💬
|
| 332 | Diagnostic Test: 4 ml. of fresh venous blood will be collected from each patient on EDTA tube and will be used for detection of the following : T cell immunoglobulin G ( TIgG) and T cell immunoglobulin M (TIgM) by | - | - | - | - | [1] 49 49 💬
|
| 333 | Diagnostic Test: Angiotensin Converting Enzyme test | - | - | - | - | [1] 49 49 💬
|
| 334 | Diagnostic Test: Anti phospholipid marker | - | - | - | - | [1] 49 49 💬
|
| 335 | Diagnostic Test: Antinuclear Antibody tests (ANA) | - | - | - | - | [1] 49 49 💬
|
| 336 | Diagnostic Test: Blood sample | - | - | - | - | [7] 10 10, 13, 49, 85, 271, 298, 299 💬
|
| 337 | Diagnostic Test: Blood samples | - | - | - | - | [4] 6 6, 49, 56, 235 💬
|
| 338 | Diagnostic Test: Blood sampling | - | - | - | - | [8] 49 49, 51, 65, 74, 97, 127, 231, 299 💬
|
| 339 | Diagnostic Test: C3 and C4 complement level. | - | - | - | - | [1] 49 49 💬
|
| 340 | Diagnostic Test: Carotid Ultrasound | - | - | - | - | [2] 46 46, 49 💬
|
| 341 | Diagnostic Test: CBC | - | - | - | - | [1] 49 49 💬
|
| 342 | Diagnostic Test: Clinical laboratory evaluations - Biochemistry | - | - | - | - | [1] 49 49 💬
|
| 343 | Diagnostic Test: Clinical laboratory evaluations - Hematology | - | - | - | - | [1] 49 49 💬
|
| 344 | Diagnostic Test: Clinical laboratory evaluations - Serology | - | - | - | - | [1] 49 49 💬
|
| 345 | Diagnostic Test: Cytokines and chemokine profiling | - | - | - | - | [1] 49 49 💬
|
| 346 | Diagnostic Test: Electrocardiogram | - | - | - | - | [2] 49 49, 58 💬
|
| 347 | Diagnostic Test: fasting blood suger | - | - | - | - | [1] 49 49 💬
|
| 348 | Diagnostic Test: Fibrinogen to albumin Ratio and C-reactive to Albumin Ratio | - | - | - | - | [1] 49 49 💬
|
| 349 | Diagnostic Test: lipid profile | - | - | - | - | [1] 49 49 💬
|
| 350 | Diagnostic Test: Physical examination | - | - | - | - | [2] 49 49, 172 💬
|
| 351 | Diagnostic Test: Pregnancy Test | - | - | - | - | [1] 49 49 💬
|
| 352 | Diagnostic Test: Rest of ANA profile | - | - | - | - | [1] 49 49 💬
|
| 353 | Diagnostic Test: serum ceramides level in blood | - | - | - | - | [1] 49 49 💬
|
| 354 | Diagnostic Test: Serum creatinine and Alb/create ratio | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [1] 49 49 💬
|
| 355 | Diagnostic Test: SLE activity evaluation | - | - | - | - | [1] 49 49 💬
|
| 356 | Diagnostic Test: SLE biomarker profiling | - | - | - | - | [1] 49 49 💬
|
| 357 | Diagnostic Test: Urinalysis | - | - | - | - | [1] 49 49 💬
|
| 358 | Dihydroartemisinin tablet | - | - | - | - | [1] 49 49 💬
|
| 359 | Dimethylfumarat | - | - | - | - | [1] 49 49 💬
|
| 360 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [12] 11 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
|
| 361 | Diphenhydramine hydrochloride | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 11 11, 49, 222 💬
|
| 362 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] Dipyridamole
Dipyridamole
💬
| [2] PDE4A PDE4A, PDE5A 💬
| [5] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 46 46, 49, 51, 66, 96, 222, 224 💬
|
| 363 | Divozilimab | [1] Divozilimab Divozilimab | [1] Divozilimab
Divozilimab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 13 13, 49, 51 💬
|
| 364 | Docosahexaenoic acid | - | - | - | - | [4] 49 49, 90, 240, 299 💬
|
| 365 | Doppler ultrasound | - | - | - | - | [1] 49 49 💬
|
| 366 | Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom | - | - | - | - | [2] 46 46, 49 💬
|
| 367 | DS-7011a | - | - | - | - | [1] 49 49 💬
|
| 368 | DZP | - | - | - | - | [1] 49 49 💬
|
| 369 | E6742 | - | - | - | - | [1] 49 49 💬
|
| 370 | Edratide | [1] Edratide Edratide | [1] Edratide
Edratide
💬
| - | - | [1] 49 49 💬
|
| 371 | Edratide Acetate | [2] Acetate Acetate, Edratide | [1] Edratide
Edratide
💬
| - | - | [1] 49 49 💬
|
| 372 | EFAVALEUKIN ALFA | [1] Efavaleukin alfa Efavaleukin alfa | [1] Efavaleukin alfa
Efavaleukin alfa
💬
| - | - | [2] 49 49, 97 💬
|
| 373 | EG-501 | - | - | - | - | [1] 49 49 💬
|
| 374 | Eicosapentaenoic acid | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 375 | ELSUBRUTINIB | [1] Elsubrutinib Elsubrutinib | [1] Elsubrutinib
Elsubrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 49 49 💬
|
| 376 | Emapalumab | [1] Emapalumab Emapalumab | [1] Emapalumab
Emapalumab
💬
| [1] IFNG IFNG 💬
| [32] African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6] 49 49, 50, 54, 60, 65, 107 💬
|
| 377 | ENDOXAN | - | - | - | - | [6] 13 13, 28, 49, 51, 85, 162 💬
|
| 378 | Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells | - | - | - | - | [1] 49 49 💬
|
| 379 | Enpatoran | [1] Enpatoran Enpatoran | [1] Enpatoran
Enpatoran
💬
| [2] TLR7 TLR7, TLR8 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 380 | Enpatoran 25mg | [1] Enpatoran Enpatoran | [1] Enpatoran
Enpatoran
💬
| [2] TLR7 TLR7, TLR8 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 381 | Enpatoran 50mg | [1] Enpatoran Enpatoran | [1] Enpatoran
Enpatoran
💬
| [2] TLR7 TLR7, TLR8 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 382 | Enpatoran high dose | [1] Enpatoran Enpatoran | [1] Enpatoran
Enpatoran
💬
| [2] TLR7 TLR7, TLR8 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 383 | Enpatoran low dose | [1] Enpatoran Enpatoran | [1] Enpatoran
Enpatoran
💬
| [2] TLR7 TLR7, TLR8 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 384 | Enpatoran medium dose | [1] Enpatoran Enpatoran | [1] Enpatoran
Enpatoran
💬
| [2] TLR7 TLR7, TLR8 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 385 | Enteric-Coated Mycophenolate Sodium | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 49 49 💬
|
| 386 | Envudeucitinib | [1] Envudeucitinib Envudeucitinib | [1] Envudeucitinib
Envudeucitinib
💬
| [1] TYK2 TYK2 💬
| [17] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | [1] 49 49 💬
|
| 387 | EPA and DHA supplementation | - | - | - | - | [2] 48 48, 49 💬
|
| 388 | Epatuzumab | - | - | - | - | [1] 49 49 💬
|
| 389 | EPRATUZUMAB | [1] Epratuzumab Epratuzumab | [1] Epratuzumab
Epratuzumab
💬
| [1] CD22 CD22 💬
| [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 390 | Epratuzumab 100 mg | [1] Epratuzumab Epratuzumab | [1] Epratuzumab
Epratuzumab
💬
| [1] CD22 CD22 💬
| [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 391 | Epratuzumab 1200 mg | [1] Epratuzumab Epratuzumab | [1] Epratuzumab
Epratuzumab
💬
| [1] CD22 CD22 💬
| [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 392 | Epratuzumab 400 mg | [1] Epratuzumab Epratuzumab | [1] Epratuzumab
Epratuzumab
💬
| [1] CD22 CD22 💬
| [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 393 | Epratuzumab 600 mg | [1] Epratuzumab Epratuzumab | [1] Epratuzumab
Epratuzumab
💬
| [1] CD22 CD22 💬
| [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 394 | Epratuzumab iv | [1] Epratuzumab Epratuzumab | [1] Epratuzumab
Epratuzumab
💬
| [1] CD22 CD22 💬
| [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 395 | Epratuzumab sc | [1] Epratuzumab Epratuzumab | [1] Epratuzumab
Epratuzumab
💬
| [1] CD22 CD22 💬
| [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 396 | Equecabtagene autoleucel | [1] Equecabtagene autoleucel Equecabtagene autoleucel | - | - | - | [1] 49 49 💬
|
| 397 | Equecabtagene Autoleucel Injection | [1] Equecabtagene autoleucel Equecabtagene autoleucel | - | - | - | [1] 49 49 💬
|
| 398 | ERL080A | - | - | - | - | [1] 49 49 💬
|
| 399 | Estradiol | [1] Estradiol Estradiol | [2] Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [9] 13 13, 46, 49, 65, 76, 78, 118, 226, 299 💬
|
| 400 | Ethinyl estradiol | [1] Estradiol Estradiol | [2] Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 49 49 💬
|
| 401 | Ethylhydrogenfumarat, Calciumsalz | - | - | - | - | [1] 49 49 💬
|
| 402 | Ethylhydrogenfumarat, Magnesiumsalz | - | - | - | - | [1] 49 49 💬
|
| 403 | Ethylhydrogenfumarat, Zinksalz | - | - | - | - | [1] 49 49 💬
|
| 404 | EVM18001 Injection | - | - | - | - | [3] 11 11, 49, 51 💬
|
| 405 | EVOBRUTINIB | [1] Evobrutinib Evobrutinib | [1] Evobrutinib
Evobrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [3] 13 13, 46, 49 💬
|
| 406 | Extended release dipyridamole 200mg/aspirin 25mg | [1] Dipyridamole Dipyridamole | [1] Dipyridamole
Dipyridamole
💬
| [2] PDE4A PDE4A, PDE5A 💬
| [5] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 49 49 💬
|
| 407 | Extra Virgin Olive Oil (EVOO) | [1] Olive oil Olive oil | [1] Olive oil
Olive oil
💬
| - | - | [1] 49 49 💬
|
| 408 | Ezetimibe | [1] Ezetimibe Ezetimibe | [1] Ezetimibe
Ezetimibe
💬
| [1] NPC1L1 NPC1L1 💬
| [1] Fat digestion and absorption Fat digestion and absorption 💬 | [5] 49 49, 79, 93, 149, 260 💬
|
| 409 | Ezetimibe+Simvastatin Drug Combination | [2] Ezetimibe Ezetimibe, Simvastatin | [2] Simvastatin
Simvastatin
,
Ezetimibe
💬
| [2] HMGCR HMGCR, NPC1L1 💬
| [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Fat digestion and absorption, Terpenoid backbone biosynthesis 💬 | [1] 49 49 💬
|
| 410 | Fan beam CT scan | - | - | - | - | [1] 49 49 💬
|
| 411 | Fecal microbiota | [1] Fecal microbiota Fecal microbiota | - | - | - | [14] 2 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
|
| 412 | Filgrastim | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [30] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 413 | Firsekibart | - | - | - | - | [2] 49 49, 54 💬
|
| 414 | Fish Oil | [1] Fish oil Fish oil | - | - | - | [10] 13 13, 46, 49, 50, 66, 79, 96, 260, 294, 299 💬
|
| 415 | Flash glucose monitoring system | - | - | - | - | [1] 49 49 💬
|
| 416 | Flow-mediated dilation of the brachial artery | - | - | - | - | [1] 49 49 💬
|
| 417 | Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [30] 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 418 | Fludarabine phosphate | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [14] 28 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
|
| 419 | Fluoropyrimidine | - | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 420 | Fluzone | - | - | - | - | [1] 49 49 💬
|
| 421 | Focetria (Monovalent MF59-Adjuvanted vaccine) | - | - | - | - | [3] 46 46, 49, 271 💬
|
| 422 | FolateScan (Technetium Tc 99mEC20) | - | - | - | - | [4] 13 13, 46, 49, 96 💬
|
| 423 | Folic acid | [1] Folic acid Folic acid | [2] Folic acid
Folic acid
,
Folate sodium
💬
| - | - | [9] 6 6, 46, 49, 50, 84, 97, 118, 172, 296 💬
|
| 424 | Forigerimod | [1] Forigerimod Forigerimod | [1] Forigerimod
Forigerimod
💬
| - | - | [1] 49 49 💬
|
| 425 | Fostamatinib | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [5] 46 46, 49, 61, 63, 66 💬
|
| 426 | Fostamatinib Disodium (R935788) | [1] Fostamatinib Fostamatinib | [2] Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| [1] SYK SYK 💬
| [18] B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 49 💬
|
| 427 | FT819 | - | - | - | - | [3] 49 49, 50, 51 💬
|
| 428 | Fumaderm® | - | - | - | - | [1] 49 49 💬
|
| 429 | Fumaderm® initial | - | - | - | - | [1] 49 49 💬
|
| 430 | Gardasil | - | - | - | - | [1] 49 49 💬
|
| 431 | Gazyvaro | - | - | - | - | [2] 49 49, 222 💬
|
| 432 | GB261 | - | - | - | - | [1] 49 49 💬
|
| 433 | GC+HCQ | - | - | - | - | [1] 49 49 💬
|
| 434 | GC012F | [1] GC012F GC012F | - | - | - | [6] 11 11, 13, 28, 46, 49, 51 💬
|
| 435 | GC012F injection | [1] GC012F GC012F | - | - | - | [4] 11 11, 28, 49, 51 💬
|
| 436 | GDC-0853 | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 437 | GDC-0853 RO7010939 | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 438 | Genetic: ALLO-329 | - | - | - | - | [2] 49 49, 51 💬
|
| 439 | Genetic: Blood sampling | - | - | - | - | [2] 13 13, 49 💬
|
| 440 | Genetic: Genotype Detection | - | - | - | - | [1] 49 49 💬
|
| 441 | Genetic: Polymorphism Analysis | - | - | - | - | [2] 49 49, 60 💬
|
| 442 | Genetic: Taking peripheral blood samples | - | - | - | - | [1] 49 49 💬
|
| 443 | GL701 | - | - | - | - | [1] 49 49 💬
|
| 444 | GLPG3667 | - | - | - | - | [2] 49 49, 50 💬
|
| 445 | GLPG3970 film-coated tablet | - | - | - | - | [1] 49 49 💬
|
| 446 | GlucoCorticoid | - | - | - | - | [7] 46 46, 49, 66, 113, 223, 228, 300 💬
|
| 447 | Glucocorticoids | - | - | - | - | [13] 35 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
|
| 448 | GNC-038 | - | - | - | - | [2] 46 46, 49 💬
|
| 449 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 450 | GR1803 injection | - | - | - | - | [1] 49 49 💬
|
| 451 | Group A SLE prospective study | - | - | - | - | [1] 49 49 💬
|
| 452 | Growth colony stimulating factor (G-CSF) | - | - | - | - | [1] 49 49 💬
|
| 453 | GSK1550188 | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 454 | GSK1550188 1mg/kg or 10mg/kg | - | - | - | - | [1] 49 49 💬
|
| 455 | GSK1550188 IV | - | - | - | - | [1] 49 49 💬
|
| 456 | GSK1550188 SC | - | - | - | - | [1] 49 49 💬
|
| 457 | GSK2586184 | - | - | - | - | [1] 49 49 💬
|
| 458 | GSK2586184 100 mg | - | - | - | - | [1] 49 49 💬
|
| 459 | GSK2586184 200 mg | - | - | - | - | [1] 49 49 💬
|
| 460 | GSK2586184 400 mg | - | - | - | - | [1] 49 49 💬
|
| 461 | GSK2586184 50 mg | - | - | - | - | [1] 49 49 💬
|
| 462 | GSK2586184 800mg single and repeat dose | - | - | - | - | [1] 49 49 💬
|
| 463 | GSK2586184 new formulation | - | - | - | - | [1] 49 49 💬
|
| 464 | GSK2586184 standard formulation | - | - | - | - | [1] 49 49 💬
|
| 465 | GSK4347859 | - | - | - | - | [1] 49 49 💬
|
| 466 | GSK4527363 | - | - | - | - | [1] 49 49 💬
|
| 467 | GSK5926371 | - | - | - | - | [1] 49 49 💬
|
| 468 | Gusacitinib | [1] Gusacitinib Gusacitinib | [1] Gusacitinib
Gusacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, SYK 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neutrophil extracellular trap formation, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 49 49 💬
|
| 469 | H.P. Acthar Gel | - | - | - | - | [5] 46 46, 49, 50, 84, 222 💬
|
| 470 | HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM | - | - | - | - | [2] 6 6, 49 💬
|
| 471 | HB-adMSCs | - | - | - | - | [8] 2 2, 4, 6, 13, 14, 46, 49, 113 💬
|
| 472 | HB2198 | - | - | - | - | [1] 49 49 💬
|
| 473 | HBI0101 CART | - | - | - | - | [5] 11 11, 13, 46, 49, 51 💬
|
| 474 | HBM7020 | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 475 | HC022 | - | - | - | - | [1] 49 49 💬
|
| 476 | HCQ | - | - | - | - | [2] 46 46, 49 💬
|
| 477 | Hematopoietic Cell Transplantation | - | - | - | - | [2] 49 49, 60 💬
|
| 478 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [13] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
|
| 479 | Herpes Zoster Subunit (HZ/su) Vaccine | - | - | - | - | [1] 49 49 💬
|
| 480 | HGS1006 | - | - | - | - | [1] 49 49 💬
|
| 481 | HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA | - | - | - | - | [2] 49 49, 53 💬
|
| 482 | High Dietary Sodium | - | - | - | - | [1] 49 49 💬
|
| 483 | High dose GR1603 in phase ? | - | - | - | - | [1] 49 49 💬
|
| 484 | High dose GR1603 in phase?b | - | - | - | - | [1] 49 49 💬
|
| 485 | High Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 💬
|
| 486 | High-intensity lipid-lowering therapy | - | - | - | - | [2] 46 46, 49 💬
|
| 487 | Hiomega-3 supplement of Naturalis® company - | - | - | - | - | [1] 49 49 💬
|
| 488 | HLL2 | - | - | - | - | [1] 49 49 💬
|
| 489 | HLL2 (Epratuzumab) | [1] Epratuzumab Epratuzumab | [1] Epratuzumab
Epratuzumab
💬
| [1] CD22 CD22 💬
| [3] B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 490 | HLL2 (trivial name or chemical description) | - | - | - | - | [1] 49 49 💬
|
| 491 | HLL2,IMMU-103 | - | - | - | - | [1] 49 49 💬
|
| 492 | HN2301 injection | - | - | - | - | [4] 11 11, 46, 49, 51 💬
|
| 493 | HN2302 Injection | - | - | - | - | [3] 11 11, 49, 51 💬
|
| 494 | HPV prophylactic vaccine Gardasil | - | - | - | - | [1] 49 49 💬
|
| 495 | HrIL-2 active | - | - | - | - | [3] 46 46, 49, 53 💬
|
| 496 | HUC-MSCs treatment (Double dose) | - | - | - | - | [1] 49 49 💬
|
| 497 | HUC-MSCs treatment (high dose) | - | - | - | - | [1] 49 49 💬
|
| 498 | HUC-MSCs treatment (low dose) | - | - | - | - | [1] 49 49 💬
|
| 499 | HUC-MSCs treatment (medium dose) | - | - | - | - | [1] 49 49 💬
|
| 500 | Human papillomavirus vaccination (Gardasil) | - | - | - | - | [1] 49 49 💬
|
| 501 | Human umbilical cord derived MSC transplantation for SLE | - | - | - | - | [1] 49 49 💬
|
| 502 | Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2 | - | - | - | - | [1] 49 49 💬
|
| 503 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [29] 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 504 | Hydroxychloroquine (Z0188) | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [1] 49 49 💬
|
| 505 | Hydroxychloroquine or Chloroquine | [2] Chloroquine Chloroquine, Hydroxychloroquine | [6] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Chloroquine phosphate
,
Chloroquine
,
Chloroquine hydrochloride
,
Chloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [1] 49 49 💬
|
| 506 | Hydroxychloroquine reduced | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [1] 49 49 💬
|
| 507 | HZN-7734, VIB7734 | - | - | - | - | [1] 49 49 💬
|
| 508 | HZN-7734, VIB7734, MEDI7734 | - | - | - | - | [1] 49 49 💬
|
| 509 | Ianalumab | [1] Ianalumab Ianalumab | [1] Ianalumab
Ianalumab
💬
| [1] TNFRSF13C TNFRSF13C 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬 | [8] 35 35, 46, 49, 51, 53, 61, 63, 95 💬
|
| 510 | IASO-782 injection | - | - | - | - | [2] 49 49, 61 💬
|
| 511 | Ibandronate | [1] Ibandronate Ibandronate | [2] Ibandronate sodium
Ibandronate sodium
,
Ibandronic acid
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [2] 46 46, 49 💬
|
| 512 | Ibandronate+alfacalcidol+calcium | [3] Alfacalcidol Alfacalcidol, Calcium, Ibandronate | [3] Alfacalcidol
Alfacalcidol
,
Ibandronate sodium
,
Ibandronic acid
💬
| [2] FDPS FDPS, VDR 💬
| [8] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬 | [1] 49 49 💬
|
| 513 | ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following cyclophosphamide-only lymphodepletion | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 49 49 💬
|
| 514 | ICI 182,780 (Faslodex) | - | - | - | - | [1] 49 49 💬
|
| 515 | ICP-022 | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 516 | IFN-a 2b Kinoid Drug Substance | - | - | - | - | [1] 49 49 💬
|
| 517 | IFN-a2b Kinoid | - | - | - | - | [1] 49 49 💬
|
| 518 | IFN-K | - | - | - | - | [2] 49 49, 50 💬
|
| 519 | IFN-Kinoid | - | - | - | - | [2] 49 49, 50 💬
|
| 520 | IFN-Kinoid Drug Substance | - | - | - | - | [2] 49 49, 50 💬
|
| 521 | IFNa-Kinoid | - | - | - | - | [2] 49 49, 50 💬
|
| 522 | Iguratimod | [1] Iguratimod Iguratimod | [1] Iguratimod
Iguratimod
💬
| [1] NFKB1 NFKB1 💬
| [76] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | [7] 46 46, 49, 51, 53, 63, 271, 300 💬
|
| 523 | IL-2 | - | - | - | - | [3] 2 2, 49, 51 💬
|
| 524 | IL-6R nanobody | - | - | - | - | [1] 49 49 💬
|
| 525 | ILT-101 | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 49 49 💬
|
| 526 | IM19 CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 527 | IMC-002 + SOC | - | - | - | - | [1] 49 49 💬
|
| 528 | IMMU-103 | - | - | - | - | [1] 49 49 💬
|
| 529 | Immune ablation and hematopoietic stem cell support. | - | - | - | - | [1] 49 49 💬
|
| 530 | IMMUNOGLOBULIN G | - | - | - | - | [9] 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
| 531 | Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer | - | - | - | - | [1] 49 49 💬
|
| 532 | Immunosuppressant other than CYC | - | - | - | - | [1] 49 49 💬
|
| 533 | Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate) | [3] Azathioprine Azathioprine, Methotrexate, Mycophenolate mofetil | [6] Methotrexate
Methotrexate
,
Azathioprine
,
Mycophenolate mofetil
,
Methotrexate sodium
,
Azathioprine sodium
,
Mycophenolate mofetil hydrochloride
💬
| [4] DHFR DHFR, DHFR2, IMPDH1, IMPDH2 💬
| [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate, Purine metabolism 💬 | [1] 49 49 💬
|
| 534 | IMPT-514 | - | - | - | - | [1] 49 49 💬
|
| 535 | IMPT-514 CART Cell Injection | - | - | - | - | [1] 49 49 💬
|
| 536 | Imvotamab | [1] Imvotamab Imvotamab | [1] Imvotamab
Imvotamab
💬
| [2] CD3E CD3E, MS4A1 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 46 46, 49 💬
|
| 537 | Inaticabtagene Autoleucel | [1] Inaticabtagene Autoleucel Inaticabtagene Autoleucel | - | - | - | [3] 49 49, 61, 63 💬
|
| 538 | Inaticabtagene autoleucel Injection | [1] Inaticabtagene Autoleucel Inaticabtagene Autoleucel | - | - | - | [3] 49 49, 61, 63 💬
|
| 539 | Individualized dose of rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 540 | INEBILIZUMAB | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [8] 11 11, 13, 46, 49, 51, 53, 95, 300 💬
|
| 541 | Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
|
| 542 | Influenz virus surface antigens | - | - | - | - | [1] 49 49 💬
|
| 543 | INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED) | - | - | - | - | [1] 49 49 💬
|
| 544 | Influvac | - | - | - | - | [3] 46 46, 49, 50 💬
|
| 545 | Interleukin 2 | - | - | - | - | [9] 46 46, 49, 51, 56, 63, 95, 96, 97, 271 💬
|
| 546 | Interleukin 23 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 547 | Interleukin-2 | - | - | - | - | [6] 2 2, 13, 49, 50, 55, 65 💬
|
| 548 | Intravenous Immunoglobulin | - | - | - | - | [9] 13 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
|
| 549 | Ipilimumab | [1] Ipilimumab Ipilimumab | [1] Ipilimumab
Ipilimumab
💬
| [1] CTLA4 CTLA4 💬
| [4] Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Rheumatoid arthritis, T cell receptor signaling pathway 💬 | [9] 13 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
|
| 550 | IPP - 201101 | - | - | - | - | [1] 49 49 💬
|
| 551 | IPP-201101 | - | - | - | - | [1] 49 49 💬
|
| 552 | IPP-201101, P140 | - | - | - | - | [1] 49 49 💬
|
| 553 | Iscalimab | [1] Iscalimab Iscalimab | [1] Iscalimab
Iscalimab
💬
| [1] CD40 CD40 💬
| [17] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | [2] 49 49, 53 💬
|
| 554 | Isoniazid | [1] Isoniazid Isoniazid | [1] Isoniazid
Isoniazid
💬
| - | - | [2] 49 49, 254 💬
|
| 555 | Isoniazid/Pyridoxine | [2] Isoniazid Isoniazid, Pyridoxine | [3] Isoniazid
Isoniazid
,
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | [1] 49 49 💬
|
| 556 | Itolizumab | [1] Itolizumab Itolizumab | [1] Itolizumab
Itolizumab
💬
| [1] CD6 CD6 💬
| [1] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction 💬 | [2] 49 49, 50 💬
|
| 557 | Itolizumab [Bmab 600] | [1] Itolizumab Itolizumab | [1] Itolizumab
Itolizumab
💬
| [1] CD6 CD6 💬
| [1] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction 💬 | [1] 49 49 💬
|
| 558 | JBT-101 | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 49 49, 50, 51, 299 💬
|
| 559 | JMKX000189 | - | - | - | - | [1] 49 49 💬
|
| 560 | JNJ-54767414 | - | - | - | - | [2] 28 28, 49 💬
|
| 561 | JNJ-55920839 | - | - | - | - | [1] 49 49 💬
|
| 562 | JNJ-56022473 | - | - | - | - | [1] 49 49 💬
|
| 563 | JNJ-80202135 | - | - | - | - | [5] 11 11, 14, 46, 49, 53 💬
|
| 564 | JY231 injection | - | - | - | - | [1] 49 49 💬
|
| 565 | Ketogenic Diet | - | - | - | - | [7] 13 13, 21, 49, 77, 127, 145, 148 💬
|
| 566 | KINERET | - | - | - | - | [8] 41 41, 49, 54, 57, 65, 106, 266, 299 💬
|
| 567 | KITE-363 | - | - | - | - | [5] 11 11, 13, 14, 49, 51 💬
|
| 568 | KK4277 | - | - | - | - | [1] 49 49 💬
|
| 569 | KN5501 cell injection | - | - | - | - | [1] 49 49 💬
|
| 570 | KN5601 | - | - | - | - | [1] 49 49 💬
|
| 571 | KP104 | - | - | - | - | [4] 49 49, 62, 66, 223 💬
|
| 572 | KPG-818 | - | - | - | - | [1] 49 49 💬
|
| 573 | KPG-818 high dose | - | - | - | - | [1] 49 49 💬
|
| 574 | KPG-818 low dose | - | - | - | - | [1] 49 49 💬
|
| 575 | KPG-818 mid dose | - | - | - | - | [1] 49 49 💬
|
| 576 | KZR-616 | - | - | - | - | [4] 49 49, 50, 61, 63 💬
|
| 577 | L04AA26 | - | - | - | - | [1] 49 49 💬
|
| 578 | LA294 | - | - | - | - | [1] 49 49 💬
|
| 579 | Lacteol forte capsules | - | - | - | - | [1] 49 49 💬
|
| 580 | Lamivudine | [1] Lamivudine Lamivudine | [1] Lamivudine
Lamivudine
💬
| - | - | [10] 2 2, 26, 42, 46, 49, 135, 156, 223, 265, 325 💬
|
| 581 | LAQUINIMOD | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [4] 8 8, 13, 49, 96 💬
|
| 582 | LBL-047 for Injection | - | - | - | - | [1] 49 49 💬
|
| 583 | LCAR-AIO T cells | - | - | - | - | [3] 11 11, 13, 49 💬
|
| 584 | Leflunomide | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [14] 11 11, 40, 46, 49, 53, 54, 66, 107, 162, 223, 224, 270, 271, 300 💬
|
| 585 | Lenalidomide | [1] Lenalidomide Lenalidomide | [1] Lenalidomide
Lenalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [9] 16 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
|
| 586 | Leukapheresis | - | - | - | - | [6] 49 49, 51, 85, 96, 284, 285 💬
|
| 587 | Levothyroxine | [1] Levothyroxine Levothyroxine | [3] Levothyroxine sodium
Levothyroxine sodium
,
Levothyroxine
,
Levothyroxine sodium
💬
| [2] THRA THRA, THRB 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [3] 49 49, 78, 80 💬
|
| 588 | Lisinopril | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [9] 19 19, 46, 49, 57, 66, 67, 113, 222, 223 💬
|
| 589 | Lisinopril Pills | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 49 49 💬
|
| 590 | Litifilimab | [1] Litifilimab Litifilimab | [1] Litifilimab
Litifilimab
💬
| - | - | [1] 49 49 💬
|
| 591 | LJP 394 | - | - | - | - | [1] 49 49 💬
|
| 592 | LJP394 | - | - | - | - | [1] 49 49 💬
|
| 593 | LMY-920 | - | - | - | - | [1] 49 49 💬
|
| 594 | Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) | [2] Acetate Acetate, Estradiol | [2] Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [2] 46 46, 49 💬
|
| 595 | Low Dietary Sodium | - | - | - | - | [1] 49 49 💬
|
| 596 | Low dose GR1603 in phase ? | - | - | - | - | [1] 49 49 💬
|
| 597 | Low dose GR1603 in phase ?b | - | - | - | - | [1] 49 49 💬
|
| 598 | Low Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 💬
|
| 599 | Low-dose Aldesleukin (Proleukin®) | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 49 49 💬
|
| 600 | Low-Dose Naltrexone (LDN) | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 13 13, 46, 49 💬
|
| 601 | Low-Frequency Electromagnetic Resonance Therapy (LF-EMR) | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 602 | LUCAR-G79D T cells | - | - | - | - | [1] 49 49 💬
|
| 603 | Lulizumab Pegol | [1] Lulizumab pegol Lulizumab pegol | - | - | - | [1] 49 49 💬
|
| 604 | Lupuzor | - | - | - | - | [1] 49 49 💬
|
| 605 | LVIVO-TaVec400 product | - | - | - | - | [4] 11 11, 13, 49, 300 💬
|
| 606 | LY2127399 | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 607 | LY3009104 | - | - | - | - | [10] 46 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
|
| 608 | LY3361237 | - | - | - | - | [2] 49 49, 53 💬
|
| 609 | LY3471851 | - | - | - | - | [2] 49 49, 97 💬
|
| 610 | LY4298445 | - | - | - | - | [2] 46 46, 49 💬
|
| 611 | Lymphodepleting Chemotherapy | - | - | - | - | [3] 49 49, 51, 300 💬
|
| 612 | LymphoStat-B | - | - | - | - | [1] 49 49 💬
|
| 613 | LymphoStat-B (LSB), monoclonal anti-Blys, LSB | - | - | - | - | [1] 49 49 💬
|
| 614 | LymphoStat-B TM | - | - | - | - | [1] 49 49 💬
|
| 615 | LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA® | - | - | - | - | [1] 49 49 💬
|
| 616 | M281 | - | - | - | - | [5] 11 11, 46, 49, 53, 61 💬
|
| 617 | M2951 | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 618 | M5049 | - | - | - | - | [1] 49 49 💬
|
| 619 | M5049 high dose | - | - | - | - | [2] 49 49, 50 💬
|
| 620 | M5049 low dose | - | - | - | - | [1] 49 49 💬
|
| 621 | M5049 medium dose | - | - | - | - | [1] 49 49 💬
|
| 622 | MabThera (Rituximab) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4] 13 13, 46, 49, 53 💬
|
| 623 | MB-CART19.1 | - | - | - | - | [1] 49 49 💬
|
| 624 | MC-1 | [1] MC-1 MC-1 | - | - | - | [1] 49 49 💬
|
| 625 | MC-1-50 | [1] MC-1 MC-1 | - | - | - | [1] 49 49 💬
|
| 626 | MEDI 545 | - | - | - | - | [1] 49 49 💬
|
| 627 | MEDI-545 | - | - | - | - | [2] 49 49, 50 💬
|
| 628 | MEDI-545 600 | - | - | - | - | [1] 49 49 💬
|
| 629 | MEDI-546 | - | - | - | - | [2] 49 49, 51 💬
|
| 630 | MEDI-570 0.03 MG | - | - | - | - | [1] 49 49 💬
|
| 631 | MEDI-570 0.1 MG | - | - | - | - | [1] 49 49 💬
|
| 632 | MEDI-570 0.3 MG | - | - | - | - | [1] 49 49 💬
|
| 633 | MEDI-570 1 MG | - | - | - | - | [1] 49 49 💬
|
| 634 | Medroxyprogesterone | - | - | - | - | [1] 49 49 💬
|
| 635 | Melatonin | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬
| [2] MTNR1A MTNR1A, MTNR1B 💬
| [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [18] 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
|
| 636 | Meloxicam | [1] Meloxicam Meloxicam | [1] Meloxicam
Meloxicam
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [4] 46 46, 49, 271, 296 💬
|
| 637 | Memantine | [1] Memantine Memantine | [2] Memantine hydrochloride
Memantine hydrochloride
,
Memantine
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [8] 2 2, 6, 8, 13, 49, 127, 205, 206 💬
|
| 638 | Mesenchymal stem cells | - | - | - | - | [16] 2 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 107, 222, 271, 274, 298, 299 💬
|
| 639 | Mesna | [1] Coenzyme M Coenzyme M | [1] Mesna
Mesna
💬
| - | - | [12] 11 11, 13, 16, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
| 640 | Metabolically Armed CD19 CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 641 | Metformin | [1] Metformin Metformin | [2] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| [2] PRKAA1 PRKAA1, PRKAA2 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [31] 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
|
| 642 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 643 | Methotrexate and folic acid | [2] Folic acid Folic acid, Methotrexate | [4] Folic acid
Folic acid
,
Methotrexate
,
Methotrexate sodium
,
Folate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 49 49 💬
|
| 644 | Methyl prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 43 43, 49, 96 💬
|
| 645 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 646 | Methylprednisolone (Corticosteroid) | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 647 | METHYLPREDNISOLONE SODIUM SUCCINATE | [3] Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate, Succinic acid | [4] Methylprednisolone
Methylprednisolone
,
Methylprednisolone sodium succinate
,
Methylprednisolone acetate
,
Methylprednisolone hemisuccinate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 13 13, 46, 49, 50, 51, 211, 222 💬
|
| 648 | MHS552 | - | - | - | - | [1] 49 49 💬
|
| 649 | MICOFENOLATO MOFETILE | - | - | - | - | [2] 49 49, 53 💬
|
| 650 | MICOFENOLICO ACIDO | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 49 49 💬
|
| 651 | MIL62 | - | - | - | - | [3] 13 13, 49, 222 💬
|
| 652 | Milatuzumab | [1] Milatuzumab Milatuzumab | [1] Milatuzumab
Milatuzumab
💬
| [1] CD74 CD74 💬
| [3] Antigen processing and presentation Antigen processing and presentation, Herpes simplex virus 1 infection, Tuberculosis 💬 | [1] 49 49 💬
|
| 653 | Milnacipran | [1] Milnacipran Milnacipran | [2] Milnacipran hydrochloride
Milnacipran hydrochloride
,
Milnacipran
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 46 46, 49 💬
|
| 654 | Mizoribine | [1] Mizoribine Mizoribine | [1] Mizoribine
Mizoribine
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [8] 46 46, 49, 51, 53, 66, 94, 222, 224 💬
|
| 655 | MK-1045 | - | - | - | - | [2] 46 46, 49 💬
|
| 656 | MK-6194 | - | - | - | - | [2] 49 49, 97 💬
|
| 657 | MODAFINIL | [1] Modafinil Modafinil | [1] Modafinil
Modafinil
💬
| - | - | [6] 6 6, 13, 49, 93, 96, 97 💬
|
| 658 | Moderna mRNA-1273 | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 659 | Moderna mRNA-1273, Bivalent | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 660 | Monovalent [B.1.351] CoV2 preS dTM-AS03 | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 661 | Mosunetuzumab | [1] Mosunetuzumab Mosunetuzumab | [1] Mosunetuzumab
Mosunetuzumab
💬
| [2] CD3E CD3E, MS4A1 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 49 49 💬
|
| 662 | Moxifloxacin | [1] Moxifloxacin Moxifloxacin | [3] Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
,
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | [10] 2 2, 6, 46, 49, 85, 86, 113, 226, 240, 299 💬
|
| 663 | MRA 003 US | - | - | - | - | [1] 49 49 💬
|
| 664 | MRI, Venipuncture | - | - | - | - | [1] 49 49 💬
|
| 665 | MRNA COVD19 vaccine | - | - | - | - | [4] 49 49, 53, 97, 271 💬
|
| 666 | MSC treatment | - | - | - | - | [2] 49 49, 223 💬
|
| 667 | MSC2364447C | - | - | - | - | [2] 13 13, 49 💬
|
| 668 | MT-1303 High dose | - | - | - | - | [1] 49 49 💬
|
| 669 | MT-1303 Low dose | - | - | - | - | [1] 49 49 💬
|
| 670 | MTS109 | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 671 | Multivitamin | - | - | - | - | [2] 49 49, 118 💬
|
| 672 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 673 | Mycophenolate mofetil (MMF) | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [8] 13 13, 49, 51, 60, 65, 66, 222, 223 💬
|
| 674 | Mycophenolate Mofetil 500mg | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [3] 49 49, 51, 61 💬
|
| 675 | Mycophenolate motetil | - | - | - | - | [1] 49 49 💬
|
| 676 | Mycophenolate sodium | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [6] 49 49, 53, 66, 222, 223, 228 💬
|
| 677 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [9] 11 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
|
| 678 | Myfortic | - | - | - | - | [5] 49 49, 66, 222, 223, 228 💬
|
| 679 | MYFORTIC*50CPR RIV 360MG | - | - | - | - | [1] 49 49 💬
|
| 680 | N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | - | - | - | - | [1] 49 49 💬
|
| 681 | N-Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [14] 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
|
| 682 | Naltrexone | [1] Naltrexone Naltrexone | [2] Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [14] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
|
| 683 | Nelfinavir | [1] Nelfinavir Nelfinavir | [2] Nelfinavir mesylate
Nelfinavir mesylate
,
Nelfinavir
💬
| - | - | [3] 49 49, 265, 331 💬
|
| 684 | NI-0501 | - | - | - | - | [3] 49 49, 54, 107 💬
|
| 685 | Nicotinamide | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [19] 2 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
|
| 686 | Nicotinamide riboside | [2] Nicotinamide Nicotinamide, Nicotinamide riboside | [1] Niacinamide
Niacinamide
💬
| - | - | [14] 2 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 97, 191 💬
|
| 687 | Nipocalimab | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬
| - | - | [6] 11 11, 14, 46, 49, 53, 61 💬
|
| 688 | Nivolumab | [1] Nivolumab Nivolumab | [1] Nivolumab
Nivolumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 689 | NK 010 or NK042 | - | - | - | - | [1] 49 49 💬
|
| 690 | NK510 : allogeneic genetic modified NK | - | - | - | - | [1] 49 49 💬
|
| 691 | NKX019 | - | - | - | - | [4] 46 46, 49, 51, 222 💬
|
| 692 | NNC 0151-0000-0000 | - | - | - | - | [2] 46 46, 49 💬
|
| 693 | NNC0114-0006 | [1] NNC0114-0006 NNC0114-0006 | - | - | - | [3] 46 46, 49, 96 💬
|
| 694 | NON APPLICABILE | - | - | - | - | [3] 49 49, 51, 256 💬
|
| 695 | Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT) | - | - | - | - | [1] 49 49 💬
|
| 696 | Norethindrone | - | - | - | - | [2] 13 13, 49 💬
|
| 697 | Normal Saline | - | - | - | - | [20] 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 71, 79, 94, 96, 97, 210, 211, 226, 276, 296, 299 💬
|
| 698 | NOX-E36 | - | - | - | - | [1] 49 49 💬
|
| 699 | NTR1011 | - | - | - | - | [2] 46 46, 49 💬
|
| 700 | Obecabtagene autoleucel | [1] Obecabtagene autoleucel Obecabtagene autoleucel | [1] Obecabtagene autoleucel
Obecabtagene autoleucel
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [2] 13 13, 49 💬
|
| 701 | Obecabtagene autoleucel (obe-cel) | [1] Obecabtagene autoleucel Obecabtagene autoleucel | [1] Obecabtagene autoleucel
Obecabtagene autoleucel
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [2] 13 13, 49 💬
|
| 702 | Obexelimab | [1] Obexelimab Obexelimab | [1] Obexelimab
Obexelimab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [4] 13 13, 49, 61, 300 💬
|
| 703 | Obinutuzumab | [1] Obinutuzumab Obinutuzumab | [1] Obinutuzumab
Obinutuzumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [6] 43 43, 44, 49, 63, 222, 223 💬
|
| 704 | Obinutuzumab administration | [1] Obinutuzumab Obinutuzumab | [1] Obinutuzumab
Obinutuzumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 49 49, 222 💬
|
| 705 | Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4] 11 11, 13, 46, 49 💬
|
| 706 | OL-108 | - | - | - | - | [2] 49 49, 51 💬
|
| 707 | Olive oil | [1] Olive oil Olive oil | [1] Olive oil
Olive oil
💬
| - | - | [10] 13 13, 34, 35, 46, 49, 53, 97, 124, 162, 271 💬
|
| 708 | Olumiant | - | - | - | - | [9] 46 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
|
| 709 | Olumiant - EU/1/16/1170/001-008 | - | - | - | - | [1] 49 49 💬
|
| 710 | Olumiant - EU/1/16/1170/009-016 | - | - | - | - | [1] 49 49 💬
|
| 711 | Omacor | - | - | - | - | [1] 49 49 💬
|
| 712 | Omega-3 | - | - | - | - | [3] 46 46, 49, 79 💬
|
| 713 | Omega-3 fatty acids | [1] Omega-3 fatty acids Omega-3 fatty acids | - | - | - | [4] 13 13, 49, 79, 223 💬
|
| 714 | Omega-3 Fatty Acids (EPA plus DHA) | [1] Omega-3 fatty acids Omega-3 fatty acids | - | - | - | [1] 49 49 💬
|
| 715 | ONT01 is a small molecule CD11b modulator. | - | - | - | - | [1] 49 49 💬
|
| 716 | Optional collection | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 717 | Oral prednisolone | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 49 49, 96, 145 💬
|
| 718 | Oral Prednisone 5mg | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 719 | Orelabrutinib | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [5] 13 13, 49, 53, 61, 63 💬
|
| 720 | Orelabrutinib (High Dose) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 49 49 💬
|
| 721 | Orelabrutinib (Low Dose) | [1] Orelabrutinib Orelabrutinib | [1] Orelabrutinib
Orelabrutinib
💬
| [1] BTK BTK 💬
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [1] 49 49 💬
|
| 722 | ORENCIA | - | - | - | - | [16] 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 223, 271, 300 💬
|
| 723 | ORENCIA 125 mg solution for injection in pre-filled syringe | - | - | - | - | [3] 46 46, 49, 53 💬
|
| 724 | Ortho-Novum 777 | - | - | - | - | [1] 49 49 💬
|
| 725 | Other: 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. | - | - | - | - | [1] 49 49 💬
|
| 726 | Other: Aerobic exercises | - | - | - | - | [1] 49 49 💬
|
| 727 | Other: Blood collection | - | - | - | - | [7] 15 15, 28, 36, 49, 66, 67, 223 💬
|
| 728 | Other: Blood collection for lipid profiling by LC-MS | - | - | - | - | [1] 49 49 💬
|
| 729 | Other: Blood drawing only Group C | - | - | - | - | [1] 49 49 💬
|
| 730 | Other: Blood draws | - | - | - | - | [2] 49 49, 51 💬
|
| 731 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 732 | Other: Blood sample for analysis of plasma of organochlorine pesticides concentration | - | - | - | - | [1] 49 49 💬
|
| 733 | Other: Blood sample for cell collection | - | - | - | - | [1] 49 49 💬
|
| 734 | Other: Blood sample taken at a single time point | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 735 | Other: Blood sampling | - | - | - | - | [14] 6 6, 13, 19, 46, 49, 51, 53, 58, 67, 127, 222, 266, 296, 299 💬
|
| 736 | Other: Blood sampling to include Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) | - | - | - | - | [1] 49 49 💬
|
| 737 | Other: Clinical data collection | - | - | - | - | [2] 49 49, 51 💬
|
| 738 | Other: Coaching Sessions | - | - | - | - | [1] 49 49 💬
|
| 739 | Other: Complete blood count | - | - | - | - | [2] 46 46, 49 💬
|
| 740 | Other: Concomitant Medication | - | - | - | - | [1] 49 49 💬
|
| 741 | Other: corn starch | - | - | - | - | [1] 49 49 💬
|
| 742 | Other: Drug free | - | - | - | - | [1] 49 49 💬
|
| 743 | Other: Examination | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 744 | Other: Fitbit Activity Monitor | - | - | - | - | [1] 49 49 💬
|
| 745 | Other: food questionnaire | - | - | - | - | [4] 46 46, 49, 96, 97 💬
|
| 746 | Other: Full history , clinical examination, assesment of disease activity ,Laboratory investigations ( CBC , ESR, CRP Serum creatinine and blood urea, Random plas | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [2] 46 46, 49 💬
|
| 747 | Other: Genetic data/DNA/RNA | - | - | - | - | [2] 49 49, 51 💬
|
| 748 | Other: Group B SLE one blood donation | - | - | - | - | [1] 49 49 💬
|
| 749 | Other: GSK2586184 single dose taken with food | - | - | - | - | [1] 49 49 💬
|
| 750 | Other: GSK2586184 single dose taken without food | - | - | - | - | [1] 49 49 💬
|
| 751 | Other: hair | - | - | - | - | [2] 46 46, 49 💬
|
| 752 | Other: immunologic technique | - | - | - | - | [3] 49 49, 65, 285 💬
|
| 753 | Other: ISA 51 VG | - | - | - | - | [1] 49 49 💬
|
| 754 | Other: Laboratory Biomarker Analysis | - | - | - | - | [22] 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 755 | Other: Land-based Liuzijue exercise | - | - | - | - | [1] 49 49 💬
|
| 756 | Other: Lupus Impact Tracker questionnaire | - | - | - | - | [1] 49 49 💬
|
| 757 | Other: MMF Discontinuation | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 758 | Other: MMF maintain | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 759 | Other: MTX Discontinuation | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 760 | Other: MTX maintain | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 761 | Other: Other biological samples to biobank (skin, lung and muscle biopsies | - | - | - | - | [2] 49 49, 51 💬
|
| 762 | Other: Patient questionnaires | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 763 | Other: Pharmacokinetic analysis | - | - | - | - | [1] 49 49 💬
|
| 764 | Other: PiggyBac Transposon-Mediated CD19 CAR-T Therapy | - | - | - | - | [1] 49 49 💬
|
| 765 | Other: polymerase chain reaction (PCR) technique of blood transcriptome analysis | - | - | - | - | [1] 49 49 💬
|
| 766 | Other: Progressive resisted exercise training | - | - | - | - | [1] 49 49 💬
|
| 767 | Other: PROMIS instruments | - | - | - | - | [1] 49 49 💬
|
| 768 | Other: SF-36 questionnaire | - | - | - | - | [1] 49 49 💬
|
| 769 | Other: SLE treatment | - | - | - | - | [1] 49 49 💬
|
| 770 | Other: SLEDAI scores | - | - | - | - | [1] 49 49 💬
|
| 771 | Other: Smartphone Application | - | - | - | - | [1] 49 49 💬
|
| 772 | Other: Standard care according to ESC 2021 guidelines | - | - | - | - | [2] 46 46, 49 💬
|
| 773 | Other: Standard of Care | - | - | - | - | [11] 13 13, 49, 57, 64, 79, 85, 95, 96, 97, 245, 246 💬
|
| 774 | Other: Standard therapy | - | - | - | - | [2] 49 49, 222 💬
|
| 775 | Other: Standard treatment according to the Clinical protocols | - | - | - | - | [3] 49 49, 51, 235 💬
|
| 776 | Other: Ultrasonography assessment | - | - | - | - | [1] 49 49 💬
|
| 777 | Other: urine sample | - | - | - | - | [7] 46 46, 49, 66, 177, 223, 240, 335 💬
|
| 778 | Other: Venous blood sampling | - | - | - | - | [1] 49 49 💬
|
| 779 | Other: Water-based Liuzijue exercise | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 49 49 💬
|
| 780 | Other: YTS109 cell | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 781 | Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [30] 6 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
|
| 782 | Ozone | [1] Ozone Ozone | - | - | - | [5] 49 49, 51, 70, 71, 226 💬
|
| 783 | P 140 | - | - | - | - | [1] 49 49 💬
|
| 784 | P-CD19CD20-ALLO1 Cells | - | - | - | - | [2] 13 13, 49 💬
|
| 785 | Paquinimod | [1] Paquinimod Paquinimod | - | - | - | [2] 49 49, 51 💬
|
| 786 | Paquinimod (ABR-215757) | [1] Paquinimod Paquinimod | - | - | - | [1] 49 49 💬
|
| 787 | PF-04236921 | - | - | - | - | [2] 49 49, 96 💬
|
| 788 | PF-06700841 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 789 | PF-06700841 15 mg | - | - | - | - | [1] 49 49 💬
|
| 790 | PF-06700841 25mg | - | - | - | - | [1] 49 49 💬
|
| 791 | PF-06700841 30 mg | - | - | - | - | [1] 49 49 💬
|
| 792 | PF-06700841 45 mg | - | - | - | - | [1] 49 49 💬
|
| 793 | PF-06700841 5mg | - | - | - | - | [1] 49 49 💬
|
| 794 | PF-06700841-15 | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 795 | PF-06835375 | - | - | - | - | [3] 46 46, 49, 63 💬
|
| 796 | Phosphate-buffered saline | - | - | - | - | [1] 49 49 💬
|
| 797 | Pioglitazone | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [17] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
|
| 798 | PIT565 | - | - | - | - | [2] 46 46, 49 💬
|
| 799 | Pitavastatin | [1] Pitavastatin Pitavastatin | [2] Pitavastatin calcium
Pitavastatin calcium
,
Pitavastatin magnesium
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [4] 49 49, 71, 79, 90 💬
|
| 800 | PLAQUENIL | - | - | - | - | [6] 46 46, 48, 49, 53, 84, 96 💬
|
| 801 | Plasmapheresis | - | - | - | - | [4] 11 11, 49, 113, 222 💬
|
| 802 | Platinum | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 803 | Platinum Compound | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 804 | Platinum Doublet | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 805 | Pneumovax | - | - | - | - | [5] 46 46, 49, 62, 96, 223 💬
|
| 806 | Pooled mesenchymal stem cell | - | - | - | - | [1] 49 49 💬
|
| 807 | Positron Emission Tomography | - | - | - | - | [6] 26 26, 28, 40, 46, 49, 96 💬
|
| 808 | Prasterone | [1] Prasterone Prasterone | [1] Prasterone
Prasterone
💬
| [3] AR AR, ESR1, ESR2 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 49 49 💬
|
| 809 | Prasterone (GL701) | [1] Prasterone Prasterone | [1] Prasterone
Prasterone
💬
| [3] AR AR, ESR1, ESR2 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 49 49 💬
|
| 810 | Pravastatin | [1] Pravastatin Pravastatin | [2] Pravastatin sodium
Pravastatin sodium
,
Pravastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [11] 13 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬
|
| 811 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 812 | Prednisolone/Prednisone | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 813 | PREDNISONA | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 49 49, 222 💬
|
| 814 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 815 | Prednisone acetate | [3] Acetate Acetate, Prednisone, Prednisone acetate | [2] Prednisone
Prednisone
,
Prednisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 35 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
|
| 816 | Prednisone discontinuation | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 817 | Premarin and Provera | - | - | - | - | [1] 49 49 💬
|
| 818 | Prevenar® and Pneumo23® | - | - | - | - | [1] 49 49 💬
|
| 819 | Proleukin | - | - | - | - | [2] 2 2, 49 💬
|
| 820 | PRV-3279 | - | - | - | - | [1] 49 49 💬
|
| 821 | PTOC1 | - | - | - | - | [1] 49 49 💬
|
| 822 | Pyridoxine | [1] Pyridoxine Pyridoxine | [2] Pyridoxine hydrochloride
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | [5] 49 49, 93, 145, 234, 320 💬
|
| 823 | QLS4131 for Injection. | - | - | - | - | [1] 49 49 💬
|
| 824 | QT-019B Cell Injection | - | - | - | - | [1] 49 49 💬
|
| 825 | QT-019C | - | - | - | - | [5] 11 11, 13, 49, 51, 63 💬
|
| 826 | Quinipril | - | - | - | - | [1] 49 49 💬
|
| 827 | R-salbutamol sulphate | - | - | - | - | [1] 49 49 💬
|
| 828 | R932333 | - | - | - | - | [1] 49 49 💬
|
| 829 | Rabbit | [1] Rabbit Rabbit | - | - | - | [11] 11 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
|
| 830 | Rabbit anti-thymocyte globulin | [1] Rabbit Rabbit | - | - | - | [5] 49 49, 60, 65, 285, 326 💬
|
| 831 | Rabbit antithymocyte globulin | [1] Rabbit Rabbit | - | - | - | [3] 49 49, 60, 96 💬
|
| 832 | Radiation: Fluorine F 18 Clofarabine | [1] Clofarabine Clofarabine | [1] Clofarabine
Clofarabine
💬
| [3] POLA1 POLA1, POLA2, RRM1 💬
| [5] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [4] 40 40, 46, 49, 96 💬
|
| 833 | Radiation: Total Body Irradiation | - | - | - | - | [11] 19 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
|
| 834 | Ramipril | [1] Ramipril Ramipril | [1] Ramipril
Ramipril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [10] 46 46, 49, 57, 66, 67, 113, 218, 222, 223, 257 💬
|
| 835 | RANKL/OPG ratio | - | - | - | - | [1] 49 49 💬
|
| 836 | Rapamycin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [13] 2 2, 15, 49, 51, 53, 60, 63, 67, 96, 158, 256, 278, 279 💬
|
| 837 | Rapcabtagene autoleucel | - | - | - | - | [5] 43 43, 44, 46, 49, 51 💬
|
| 838 | Raptiva | - | - | - | - | [3] 37 37, 49, 53 💬
|
| 839 | RAYOS | - | - | - | - | [1] 49 49 💬
|
| 840 | RC18 160 mg plus standard therapy | - | - | - | - | [1] 49 49 💬
|
| 841 | RC18 240 mg plus standard therapy | - | - | - | - | [1] 49 49 💬
|
| 842 | RC18 80 mg plus standard therapy | - | - | - | - | [1] 49 49 💬
|
| 843 | RD06-04 | [1] RD06-04 RD06-04 | - | - | - | [3] 49 49, 51, 53 💬
|
| 844 | RD06-04 CART Cell Injection | [1] RD06-04 RD06-04 | - | - | - | [3] 49 49, 51, 53 💬
|
| 845 | RD06-04 Cells injection | [1] RD06-04 RD06-04 | - | - | - | [1] 49 49 💬
|
| 846 | RD06-05 CAR-T Cell Injection | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 847 | RECOMBINANT FACTOR FC FUSION PROTEIN | - | - | - | - | [2] 46 46, 49 💬
|
| 848 | Recombinant Herpes Zoster Vaccine (RZV) | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 849 | Recombinant zoster vaccine | - | - | - | - | [2] 13 13, 49 💬
|
| 850 | Reduced Intensity Allogeneic Transplant | - | - | - | - | [2] 49 49, 51 💬
|
| 851 | Relma-cel | - | - | - | - | [2] 49 49, 51 💬
|
| 852 | REMICADE | - | - | - | - | [9] 46 46, 49, 56, 84, 85, 96, 97, 223, 271 💬
|
| 853 | Renal biopsy and blood sampling | - | - | - | - | [1] 49 49 💬
|
| 854 | RhuMab 2H7 | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 13 13, 46, 49 💬
|
| 855 | RhuMAb IFNalpha | - | - | - | - | [1] 49 49 💬
|
| 856 | Rigerimod | - | - | - | - | [1] 49 49 💬
|
| 857 | Rimiducid | [1] Rimiducid Rimiducid | [1] Rimiducid
Rimiducid
💬
| [1] CASP9 CASP9 💬
| [34] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬 | [7] 19 19, 49, 60, 65, 284, 285, 326 💬
|
| 858 | RIQUENT | - | - | - | - | [1] 49 49 💬
|
| 859 | Rituxan (rituximab) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 860 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 861 | Rivaroxaban | [1] Rivaroxaban Rivaroxaban | [1] Rivaroxaban
Rivaroxaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [10] 46 46, 48, 49, 56, 58, 75, 91, 210, 222, 271 💬
|
| 862 | Rixathon | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 863 | RJMty19 (CD19-CAR-DNT cells) | - | - | - | - | [1] 49 49 💬
|
| 864 | Ro 106-1443 | - | - | - | - | [1] 49 49 💬
|
| 865 | RO 496-4913 | - | - | - | - | [2] 46 46, 49 💬
|
| 866 | RO 5072759 | - | - | - | - | [1] 49 49 💬
|
| 867 | RO7010939/F13 | - | - | - | - | [1] 49 49 💬
|
| 868 | RO7507062 | - | - | - | - | [1] 49 49 💬
|
| 869 | Rontalizumab | [1] Rontalizumab Rontalizumab | [1] Rontalizumab
Rontalizumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 870 | Rosuvastatin | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [16] 6 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
|
| 871 | ROSUVASTATIN CALCIUM | [2] Calcium Calcium, Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [4] 49 49, 79, 97, 299 💬
|
| 872 | Royal jelly | [1] Royal jelly Royal jelly | [1] Royal jelly
Royal jelly
💬
| - | - | [1] 49 49 💬
|
| 873 | Rozibafusp Alfa | [1] Rozibafusp Alfa Rozibafusp Alfa | [1] Rozibafusp alfa
Rozibafusp alfa
💬
| [2] ICOSLG ICOSLG, TNFSF13B 💬
| [5] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 💬
|
| 874 | RSLV-132 | - | - | - | - | [2] 49 49, 53 💬
|
| 875 | Saccharum Lactis | - | - | - | - | [1] 49 49 💬
|
| 876 | Saliva sample | - | - | - | - | [1] 49 49 💬
|
| 877 | SAPHNELO | - | - | - | - | [2] 49 49, 53 💬
|
| 878 | SAR113244 | - | - | - | - | [1] 49 49 💬
|
| 879 | SAR441344 | - | - | - | - | [3] 13 13, 49, 53 💬
|
| 880 | SAR441344 IV | - | - | - | - | [2] 13 13, 49 💬
|
| 881 | SAR441344 SC | - | - | - | - | [2] 13 13, 49 💬
|
| 882 | SAR448501 | - | - | - | - | [2] 46 46, 49 💬
|
| 883 | SBI-087 | - | - | - | - | [2] 46 46, 49 💬
|
| 884 | SC belimumab 200 mg | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 885 | SC291 | - | - | - | - | [2] 43 43, 49 💬
|
| 886 | SCRI-CAR19v3 | - | - | - | - | [1] 49 49 💬
|
| 887 | SCTB35 injection | - | - | - | - | [1] 49 49 💬
|
| 888 | Seluang fish oil (Rasbora argyrotaenia) and synbiotic | [1] Fish oil Fish oil | - | - | - | [1] 49 49 💬
|
| 889 | SG301 SC Injection | - | - | - | - | [1] 49 49 💬
|
| 890 | Sham Resonance Device (Inactive Control) | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 891 | Shingrix | - | - | - | - | [6] 41 41, 46, 49, 51, 96, 97 💬
|
| 892 | SHR-2173 | - | - | - | - | [1] 49 49 💬
|
| 893 | SHR-2173 injection | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 894 | Sifalimumab | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 895 | Sifalimumab 1,200 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 896 | Sifalimumab 200 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 897 | Sifalimumab 600 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 898 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [22] 6 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
|
| 899 | Single dose of UC-MSCs | - | - | - | - | [1] 49 49 💬
|
| 900 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 901 | SM101 | - | - | - | - | [3] 49 49, 63, 66 💬
|
| 902 | SM934 | - | - | - | - | [1] 49 49 💬
|
| 903 | Sodium succinate | [1] Succinic acid Succinic acid | - | - | - | [11] 13 13, 46, 49, 50, 51, 81, 83, 95, 97, 211, 222 💬
|
| 904 | Solu-Medrol 1mg/kg | - | - | - | - | [1] 49 49 💬
|
| 905 | Solu-Medrol 250 mg | - | - | - | - | [1] 49 49 💬
|
| 906 | Soluble Fc receptor | - | - | - | - | [1] 49 49 💬
|
| 907 | Soluble Fc-gamma receptor IIb | - | - | - | - | [1] 49 49 💬
|
| 908 | SQ Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 49 49, 223 💬
|
| 909 | ST 36 | [1] ST-36 ST-36 | - | - | - | [2] 6 6, 49 💬
|
| 910 | Standard dose of HCQ | - | - | - | - | [1] 49 49 💬
|
| 911 | Standard dose of rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 912 | Standard of Care | - | - | - | - | [18] 6 6, 13, 49, 51, 57, 58, 63, 64, 79, 84, 96, 97, 113, 171, 223, 228, 240, 291 💬
|
| 913 | Standard of Care (SOC) | - | - | - | - | [5] 43 43, 44, 49, 85, 171 💬
|
| 914 | Standard of Care Treatment | - | - | - | - | [6] 11 11, 49, 53, 96, 245, 246 💬
|
| 915 | Standard therapy | - | - | - | - | [5] 49 49, 51, 58, 97, 195 💬
|
| 916 | Standard therapy (Excluding Immunosuppressants) | - | - | - | - | [1] 49 49 💬
|
| 917 | Standard therapy (Including Immunosuppressants) | - | - | - | - | [1] 49 49 💬
|
| 918 | Standard-of-care treatment | - | - | - | - | [1] 49 49 💬
|
| 919 | Stelara | - | - | - | - | [6] 49 49, 56, 96, 97, 269, 271 💬
|
| 920 | STELARA® | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 921 | Steroid Drug | - | - | - | - | [3] 11 11, 46, 49 💬
|
| 922 | Steroid Taper | - | - | - | - | [1] 49 49 💬
|
| 923 | STK-009 | - | - | - | - | [2] 49 49, 51 💬
|
| 924 | Stood sample | - | - | - | - | [1] 49 49 💬
|
| 925 | Stool sample | - | - | - | - | [1] 49 49 💬
|
| 926 | Subcuvia | - | - | - | - | [3] 14 14, 49, 65 💬
|
| 927 | Sugar pill | - | - | - | - | [9] 5 5, 6, 49, 67, 70, 86, 120, 206, 210 💬
|
| 928 | Sulfamethoxazole | [1] Sulfamethoxazole Sulfamethoxazole | [1] Sulfamethoxazole
Sulfamethoxazole
💬
| - | - | [8] 35 35, 44, 49, 61, 85, 223, 296, 299 💬
|
| 929 | SULFASALAZINE | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬
| - | - | [7] 46 46, 49, 86, 94, 107, 270, 271 💬
|
| 930 | Sulfasalazine Tablets | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬
| - | - | [1] 49 49 💬
|
| 931 | Surovatamig | - | - | - | - | [3] 46 46, 49, 222 💬
|
| 932 | Switch to Myfortic | - | - | - | - | [1] 49 49 💬
|
| 933 | Synbiotic | - | - | - | - | [2] 49 49, 96 💬
|
| 934 | SYNCAR-001 | - | - | - | - | [2] 49 49, 51 💬
|
| 935 | SYS6020 | - | - | - | - | [1] 49 49 💬
|
| 936 | T cell injection targeting CD19 chimeric antigen receptor | - | - | - | - | [7] 46 46, 49, 51, 53, 63, 93, 300 💬
|
| 937 | T cells transduced with chimeric antigen receptor anti-CD19 | - | - | - | - | [1] 49 49 💬
|
| 938 | TAB08 | - | - | - | - | [2] 46 46, 49 💬
|
| 939 | TABALUMAB | [1] Tabalumab Tabalumab | [1] Tabalumab
Tabalumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 💬
|
| 940 | Tabalumab Auto-Injector | [1] Tabalumab Tabalumab | [1] Tabalumab
Tabalumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 💬
|
| 941 | Tabalumab Prefilled Syringe | [1] Tabalumab Tabalumab | [1] Tabalumab
Tabalumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [2] 46 46, 49 💬
|
| 942 | TACI-Fc5 | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 46, 49 💬
|
| 943 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 944 | Tafasitamab | [1] Tafasitamab Tafasitamab | [1] Tafasitamab
Tafasitamab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [2] 49 49, 51 💬
|
| 945 | Tafasitamab and NK cells | [1] Tafasitamab Tafasitamab | [1] Tafasitamab
Tafasitamab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [2] 49 49, 51 💬
|
| 946 | TAK-079 | - | - | - | - | [3] 11 11, 49, 63 💬
|
| 947 | Teclistamab | [1] Teclistamab Teclistamab | [1] Teclistamab
Teclistamab
💬
| [2] CD3E CD3E, TNFRSF17 💬
| [13] Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [5] 28 28, 49, 50, 51, 53 💬
|
| 948 | Telitacicept | [1] Telitacicept Telitacicept | - | - | - | [14] 11 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
|
| 949 | Telitacicept 160mg | [1] Telitacicept Telitacicept | - | - | - | [3] 49 49, 66, 223 💬
|
| 950 | Telitacicept Freeze-dried powder Injection 80mg | [1] Telitacicept Telitacicept | - | - | - | [1] 49 49 💬
|
| 951 | Teprotumumab | [1] Teprotumumab Teprotumumab | [1] Teprotumumab
Teprotumumab
💬
| [1] IGF1R IGF1R 💬
| [30] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cadherin signaling, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, Integrin signaling, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 49 49 💬
|
| 952 | Thalidomide | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 2 2, 16, 20, 28, 49, 51, 53, 56, 63, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
|
| 953 | The generic name is warfarin and many producers will be involved | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [2] 48 48, 49 💬
|
| 954 | TI-0032-III injection | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 955 | Tissue sample | - | - | - | - | [1] 49 49 💬
|
| 956 | TJ202 injection | - | - | - | - | [1] 49 49 💬
|
| 957 | TLR7/8 Antagonist (10mg) | - | - | - | - | [1] 49 49 💬
|
| 958 | TLR7/8 Antagonist (2.5mg) | - | - | - | - | [1] 49 49 💬
|
| 959 | Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [26] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
|
| 960 | Tocopherol | [1] Tocopherol Tocopherol | [1] Tocopherol
Tocopherol
💬
| - | - | [7] 13 13, 49, 71, 206, 215, 257, 298 💬
|
| 961 | Toctino® | - | - | - | - | [1] 49 49 💬
|
| 962 | Tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [23] 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 963 | TOFACITINIB CITRATE | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [5] 46 46, 49, 97, 107, 271 💬
|
| 964 | TPMT | - | - | - | - | [1] 49 49 💬
|
| 965 | TQB3702 Tablets | - | - | - | - | [1] 49 49 💬
|
| 966 | TQH3906 capsule | - | - | - | - | [1] 49 49 💬
|
| 967 | Trade Name Xarelto | - | - | - | - | [2] 48 48, 49 💬
|
| 968 | Treatment :Abacavir 600 mg/lamivudine 300 mg | [2] Abacavir Abacavir, Lamivudine | [3] Lamivudine
Lamivudine
,
Abacavir sulfate
,
Abacavir
💬
| - | - | [1] 49 49 💬
|
| 969 | Trimethoprim | [1] Trimethoprim Trimethoprim | [3] Trimethoprim
Trimethoprim
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | [7] 36 36, 44, 49, 60, 61, 85, 299 💬
|
| 970 | Trimethoprim-Sulfamethoxazole | [2] Sulfamethoxazole Sulfamethoxazole, Trimethoprim | [4] Trimethoprim
Trimethoprim
,
Sulfamethoxazole
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | [3] 49 49, 61, 299 💬
|
| 971 | Triptorelin | [1] Triptorelin Triptorelin | [3] Triptorelin
Triptorelin
,
Triptorelin pamoate
,
Triptorelin acetate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [2] 49 49, 76 💬
|
| 972 | Triptorelin pamoate | [1] Triptorelin Triptorelin | [3] Triptorelin
Triptorelin
,
Triptorelin pamoate
,
Triptorelin acetate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [2] 49 49, 76 💬
|
| 973 | TRU-015 | [1] TRU-015 TRU-015 | - | - | - | [3] 46 46, 49, 222 💬
|
| 974 | Truxima | - | - | - | - | [2] 49 49, 222 💬
|
| 975 | TV-4710 | - | - | - | - | [1] 49 49 💬
|
| 976 | UB-VV410 | - | - | - | - | [1] 49 49 💬
|
| 977 | UCAR T-cell | - | - | - | - | [7] 11 11, 13, 14, 49, 51, 66, 222 💬
|
| 978 | UCAR T-cell group | - | - | - | - | [3] 11 11, 49, 61 💬
|
| 979 | UCAR-T cells | - | - | - | - | [2] 49 49, 51 💬
|
| 980 | Universal allogeneic anti-CD19/BCMA CAR T-cells | - | - | - | - | [4] 11 11, 49, 51, 61 💬
|
| 981 | Universal anti-CD70 CAR-T (CHT101) | - | - | - | - | [1] 49 49 💬
|
| 982 | Upadacitinib | [1] Upadacitinib Upadacitinib | [3] Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [12] 40 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
|
| 983 | Urine sample | - | - | - | - | [5] 49 49, 51, 61, 63, 84 💬
|
| 984 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [17] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
| 985 | Ustekinumab (approximately 6 mg/kg) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 49 49, 96 💬
|
| 986 | Ustekinumab 90 mg | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6] 49 49, 50, 56, 93, 96, 97 💬
|
| 987 | Ustekinumab 90 milligram (mg) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 49 49 💬
|
| 988 | Ustekinumab IV | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 49 49, 97 💬
|
| 989 | Ustekinumab SC | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 49 49, 97 💬
|
| 990 | UTAA91 injection | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 991 | Vaccination | - | - | - | - | [1] 49 49 💬
|
| 992 | Vaccine | - | - | - | - | [2] 49 49, 97 💬
|
| 993 | VAY736 | - | - | - | - | [9] 13 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
|
| 994 | VAY736 1ml PFS | - | - | - | - | [2] 46 46, 49 💬
|
| 995 | VAY736 2 ml PFS | - | - | - | - | [2] 46 46, 49 💬
|
| 996 | VAY736 2ml AI | - | - | - | - | [2] 46 46, 49 💬
|
| 997 | VENT-03 | - | - | - | - | [1] 49 49 💬
|
| 998 | VIB7734 | - | - | - | - | [4] 49 49, 50, 51, 53 💬
|
| 999 | VIB7734, MEDI7734 | - | - | - | - | [1] 49 49 💬
|
| 1000 | VIP | - | - | - | - | [3] 49 49, 51, 86 💬
|
| 1001 | VIS171 | - | - | - | - | [2] 49 49, 222 💬
|
| 1002 | Vitamin C | - | - | - | - | [5] 49 49, 206, 210, 211, 212 💬
|
| 1003 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [26] 3 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
|
| 1004 | Vitamin D 25(OH)D | [1] Vitamin D Vitamin D | - | - | - | [1] 49 49 💬
|
| 1005 | Vitamin D2 ( calciferol ) | - | - | - | - | [1] 49 49 💬
|
| 1006 | Vitamin D3 | - | - | - | - | [12] 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
|
| 1007 | Vitamin D3 400 IU | - | - | - | - | [1] 49 49 💬
|
| 1008 | Vitamin D3 6000 IU | - | - | - | - | [1] 49 49 💬
|
| 1009 | Vitamins: B6, B12, and folate | - | - | - | - | [1] 49 49 💬
|
| 1010 | Vobarilizumab | [1] Vobarilizumab Vobarilizumab | [1] Vobarilizumab
Vobarilizumab
💬
| - | - | [1] 49 49 💬
|
| 1011 | Voclosporin | [1] Voclosporin Voclosporin | [1] Voclosporin
Voclosporin
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 49 49, 222 💬
|
| 1012 | Vunakizumab | [1] Vunakizumab Vunakizumab | - | - | - | [4] 40 40, 49, 51, 271 💬
|
| 1013 | Vunakizumab (IL-17A inhibitor) | [1] Vunakizumab Vunakizumab | - | - | - | [1] 49 49 💬
|
| 1014 | Warfarin | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [15] 6 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
|
| 1015 | Warfarin Sodium | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [3] 48 48, 49, 222 💬
|
| 1016 | Water | [1] Water Water | [1] Water
Water
💬
| - | - | [36] 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 1017 | Withhold IS (B cell depletion therapy) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1018 | Withhold IS (MMF or MPA) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1019 | Withhold IS (MTX) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1020 | Without Anticoagulation | - | - | - | - | [1] 49 49 💬
|
| 1021 | XARELTO | - | - | - | - | [3] 48 48, 49, 210 💬
|
| 1022 | XmAb5871 | - | - | - | - | [2] 49 49, 300 💬
|
| 1023 | YK012 | - | - | - | - | [2] 49 49, 222 💬
|
| 1024 | YKST02 | - | - | - | - | [2] 49 49, 66 💬
|
| 1025 | YTB323 | - | - | - | - | [1] 49 49 💬
|
| 1026 | YTS109 cell | - | - | - | - | [6] 46 46, 48, 49, 51, 53, 61 💬
|
| 1027 | YTS109 cell injection | - | - | - | - | [2] 49 49, 63 💬
|
| 1028 | Zamtocabtagene autoleucel | [1] Zamtocabtagene autoleucel Zamtocabtagene autoleucel | - | - | - | [2] 49 49, 51 💬
|
| 1029 | Zishenqing | - | - | - | - | [1] 49 49 💬
|
| 1030 | ZM001 Injection | - | - | - | - | [1] 49 49 💬
|
| 1031 | Zostavax | - | - | - | - | [2] 46 46, 49 💬
|
| 1032 | Zostavax vaccine | - | - | - | - | [2] 46 46, 49 💬
|